Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bladder Cancer, January 2023

Free Subscription


Retrieve all available abstracts of the following 678 articles:
HTML format


Single Articles

  1. MUKHERJEE N, Ji N, Tan X, Chen CL, et al
    KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer.
    Cancer Med. 2022 Dec 29. doi: 10.1002/cam4.5579.
    Abstract     Related articles   

  2. WANG J, Chen S, Wang H, Cao J, et al
    Integrated molecular analyses of an interferon-gamma based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification.
    Heliyon. 2022;8:e12102.
    Abstract     Related articles   

  3. RIPPING TM, Rammant E, Witjes JA, Aaronson NK, et al
    Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Health Qual Life Outcomes. 2022;20:171.
    Abstract     Related articles   

  4. ZHONG W, Li J, Liu L, Hong P, et al
    Comparison of minimally invasive versus open pelvic organ-preserving radical cystectomy in female patients with bladder cancer: a multicenter propensity score matching analysis.
    World J Urol. 2022 Dec 29. doi: 10.1007/s00345-022-04232.
    Abstract     Related articles   

  5. ZHU X, Qin R, Qu K, Wang Z, et al
    Atomic Force Microscopy-based assessment of multimechanical cellular properties for classification of graded bladder cancer cells and cancer early diagnosis using machine learning analysis.
    Acta Biomater. 2022 Dec 26:S1742-7061(22)00838.
    Abstract     Related articles   

  6. HAO Y, Chen Y, He X, Han R, et al
    RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
    Biomaterials. 2022;293:121975.
    Abstract     Related articles   

  7. KANG Z, Dou Q, Huang T, Tu M, et al
    An angiogenesis‑related lncRNA signature for the prognostic prediction of patients with bladder cancer and LINC02321 promotes bladder cancer progression via the VEGFA signaling pathway.
    Mol Med Rep. 2023;27:38.
    Abstract     Related articles   

  8. ERIKSSON V, Holmkvist O, Huge Y, Johansson M, et al
    A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naive Cystectomy Patients-A Study of a Clinical Multicent
    J Pers Med. 2022;12:1769.
    Abstract     Related articles   

  9. Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/beta-Catenin pathway [Retraction].
    Cancer Manag Res. 2022;14:3525-3526.
    Abstract     Related articles   

  10. TAO ZL, Wu W, Liang LC, Pan JF, et al
    Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab.
    Front Oncol. 2022;12:1020793.
    Abstract     Related articles   

  11. AN B, Guo Z, Wang J, Zhang C, et al
    Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma.
    Front Immunol. 2022;13:1080947.
    Abstract     Related articles   

  12. LI J, Wang Y, Zhang X, Yang X, et al
    Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage.
    Clin Transl Med. 2023;13:e1149.
    Abstract     Related articles   

  13. ZHANG B, He Y, Zheng D, Shang P, et al
    Clinical efficacy and prognostic analysis of radical cystectomy plus modified ureterosigmoidostomy (Mainz II) in bladder cancer.
    Asian J Surg. 2022 Dec 26:S1015-9584(22)01765.
    Abstract     Related articles   

  14. YILMAZ H, Cinar NB, Avci IE, Telli E, et al
    The systemic inflammation response index: An independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers.
    Urol Oncol. 2022 Dec 26:S1078-1439(22)00468.
    Abstract     Related articles   

  15. Expression of Concern: Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221146361.
    Abstract     Related articles   

  16. TAFURI A, Panunzio A, Soldano A, Mazzucato G, et al
    AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy.
    Arch Ital Urol Androl. 2022;94:428-433.
    Abstract     Related articles   

  17. LORUSSO V, Doisy L, Granata AM, Gregori A, et al
    Could we safely omit a Repeat Transurethral Resection of the Bladder (re-TURB) after Hexaminolevulinate Photodynamic Diagnostics (PDD)-TURB?
    Arch Ital Urol Androl. 2022;94:424-427.
    Abstract     Related articles   

  18. KATSIMPERIS S, Tzelves L, Bellos T, Angelopoulos P, et al
    Diagnosis and management of intradiverticular bladder tumours: A pooled analysis of 498 cases.
    Arch Ital Urol Androl. 2022;94:486-491.
    Abstract     Related articles   

  19. CHEN D, Luo Z, Ye C, Luo Q, et al
    Constructing and validating nomograms to predict risk and prognostic factors of distant metastasis in urothelial bladder cancer patients: a population-based retrospective study.
    BMC Urol. 2022;22:212.
    Abstract     Related articles   

  20. DO MH, Thanh HD, To PK, Kim MS, et al
    CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity.
    Sci Rep. 2022;12:22420.
    Abstract     Related articles   

  21. WANG F, Xiang YS, Wu P, Shen AJ, et al
    Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
    Eur J Radiol. 2022;159:110664.
    Abstract     Related articles   

  22. GINSBURG KB, Bell S, Bukavina L, Schober JP, et al
    The Phenomenon of "Therapeutic" Nodal Yield at Cystectomy for Bladder Cancer: Do Not Discount the Will Rogers Effect.
    Eur Urol Open Sci. 2022;47:43-47.
    Abstract     Related articles   

    Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.
    Curr Oncol Rep. 2022 Dec 26:1-9. doi: 10.1007/s11912-022-01350.
    Abstract     Related articles   

  24. GUPTA R, Mahajan M, Sharma P, Bhardwaj S, et al
    Application of Vesical Imaging-Reporting and Data System in Evaluation of Urinary Bladder Cancer Using Multiparametric Magnetic Resonance Imaging: A Hospital-Based Cross-Sectional Study.
    Avicenna J Med. 2022;12:162-168.
    Abstract     Related articles   

    MNS16A VNTR polymorphic sequence variations of the TERT gene and bladder cancer: Correspondence.
    Curr Urol. 2022;16:116.
    Abstract     Related articles   

  26. ZHANG X, Zhang Y, Zhao L, Wang J, et al
    Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer.
    Front Immunol. 2022;13:1014638.
    Abstract     Related articles   

  27. MARTIN R, Renouf T, Rigby J, Hafeez S, et al
    Female sexual function in bladder cancer: A review of the evidence.
    BJUI Compass. 2022;4:5-23.
    Abstract     Related articles   

  28. DU X, Zhao X, Tang Y, Tang W, et al
    Construction of Pyroptosis-Related Prognostic and Immune Infiltration Signature in Bladder Cancer.
    Dis Markers. 2022;2022:6429993.
    Abstract     Related articles   

  29. TAO Y, Li X, Zhang Y, He L, et al
    TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study.
    Front Genet. 2022;13:1057302.
    Abstract     Related articles   

  30. LI S, Chen R, Raj A, Xue N, et al
    Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer.
    Front Oncol. 2022;12:1001843.
    Abstract     Related articles   

  31. ESTESO G, Felgueres MJ, Garcia-Jimenez AF, Reyburn-Vales C, et al
    BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and gammadelta T-cells that can be further expanded in vitro.
    Oncoimmunology. 2022;12:2160094.
    Abstract     Related articles   

  32. GAO F, Wang J, Yu Y, Yan J, et al
    Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform.
    Cancer Med. 2022 Dec 25. doi: 10.1002/cam4.5481.
    Abstract     Related articles   

  33. SALARI A, Ghahari M, Nowroozi A, Ghahari P, et al
    Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging.
    Clin Genitourin Cancer. 2022 Dec 7:S1558-7673(22)00259.
    Abstract     Related articles   

  34. OSSOLINSKI K, Ruman T, Ossolinski T, Ossolinska A, et al
    Monoisotopic silver nanoparticles-based mass spectrometry imaging of human bladder cancer tissue: Biomarker discovery.
    Adv Med Sci. 2022;68:38-45.
    Abstract     Related articles   

  35. AKSAKALLI T, Kozubaev B, Yapanoglu T, Utlu A, et al
    Bladder paraganglioma treated with open partial cystectomy: a case report.
    J Med Case Rep. 2022;16:479.
    Abstract     Related articles   

  36. LAI S, Wu P, Liu S, Seery S, et al
    Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
    BMC Urol. 2022;22:211.
    Abstract     Related articles   

  37. XV Y, Qiu M, Liu Z, Xiao M, et al
    Development of a 7-miRNA prognostic signature for patients with bladder cancer.
    Aging (Albany NY). 2022;14.
    Abstract     Related articles   

  38. ZHOU W, Dang L, Chong C, Cheng X, et al
    Ureteral tumor with morphological features analogous to phyllodes tumor: a unique case with concomitant urothelial carcinoma.
    Diagn Pathol. 2022;17:94.
    Abstract     Related articles   

  39. WARRICK JI, Hu W, Yamashita H, Walter V, et al
    Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
    Nat Commun. 2022;13:7920.
    Abstract     Related articles   

  40. KARIM NA, Ullah A, Wang H, Shoukier M, et al
    A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.
    Curr Oncol. 2022;29:9461-9473.
    Abstract     Related articles   

  41. LIU K, Zhao H, Alvarez-Maestro M, Gravas S, et al
    Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract.
    Curr Oncol. 2022;29:9284-9293.
    Abstract     Related articles   

  42. YAMASAKI H, Uematsu Y, Okano K, Ichikawa M, et al
    Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs.
    In Vitro Cell Dev Biol Anim. 2022;58:898-911.
    Abstract     Related articles   

  43. MURUGESAN K, Necchi A, Burn TC, Gjoerup O, et al
    Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
    ESMO Open. 2022;7:100641.
    Abstract     Related articles   

  44. BITARAF M, Muhammadnejad S, Azimzadeh A, Tanourlouee SB, et al
    Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models.
    Animal Model Exp Med. 2022;5:575-581.
    Abstract     Related articles   

  45. HE J, Dong C, Zhang H, Jiang Y, et al
    The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
    Cell Signal. 2023;102:110527.
    Abstract     Related articles   

  46. BUBE SH, Brix R, Christensen MB, Thostrup M, et al
    Surgical experience is predictive for bladder tumour resection quality.
    Scand J Urol. 2022;56.
    Abstract     Related articles   

  47. MAULHARDT H, Verco S, Baltezor M, Marin A, et al
    Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies.
    Drug Deliv Transl Res. 2023;13:503-519.
    Abstract     Related articles   

  48. MALM C, Jaremko G, Brehmer M
    S-phase - an independent prognostic marker in upper tract urothelial carcinoma.
    Scand J Urol. 2022;56.
    Abstract     Related articles   

  49. MERCIER BD, Castro DV, Pal SK
    Defining the Mycobiome in Bladder Cancer.
    Eur Urol Open Sci. 2022;48:70-71.
    Abstract     Related articles   

  50. NAKAMURA R, Hasegawa G, Ohashi K, Hashimoto T, et al
    Primary lung cancer treatable with radical resection after complete remission with pembrolizumab therapy following gemcitabine and carboplatin chemotherapy for multiple metastases of bladder cancer.
    IJU Case Rep. 2022;6:85-88.
    Abstract     Related articles   

  51. HAYAKAWA N, Kikuchi E
    A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer.
    IJU Case Rep. 2022;6:5-7.
    Abstract     Related articles   

  52. LI K, Yao T, Wang Z
    lncRNA-mediated ceRNA network in bladder cancer.
    Noncoding RNA Res. 2022;8:135-145.
    Abstract     Related articles   

  53. OSSOLINSKI K, Ruman T, Copie V, Tripet BP, et al
    Metabolomic and elemental profiling of blood serum in bladder cancer.
    J Pharm Anal. 2022;12:889-900.
    Abstract     Related articles   

  54. ZHANG P, Wu G, Zhang D, Lai WF, et al
    Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer.
    J Control Release. 2023 Jan 2:S0168-3659(23)00001.
    Abstract     Related articles   

  55. MORE SL, Fung ES, Mathis C, Schulte AM, et al
    Dermal exposure and hair dye: Assessing potential bladder cancer risk from permanent hair dye.
    Regul Toxicol Pharmacol. 2023 Jan 2:105331. doi: 10.1016/j.yrtph.2022.105331.
    Abstract     Related articles   

  56. DENG X, Liu X, Hu B, Liu J, et al
    Upregulation of MTHFD2 is associated with PD‑L1 activation in bladder cancer via the PI3K/AKT pathway.
    Int J Mol Med. 2023;51:14.
    Abstract     Related articles   

  57. KOSHKIN VS, Almassi N, Aragon-Ching JB
    Editorial: Radical cystectomy in bladder cancer patients.
    Front Oncol. 2022;12:1113112.
    Abstract     Related articles   

  58. HAGGSTROM C, Hagberg O, Gardmark T, Aljabery F, et al
    Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0.
    BMJ Open. 2022;12:e064898.
    Abstract     Related articles   

    A CAF subcluster regulates bladder cancer stemness.
    Nat Rev Urol. 2023 Jan 4. doi: 10.1038/s41585-022-00713.
    Abstract     Related articles   

  60. MOLONY RD, Wu CH, Lee YF
    E-liquid exposure induces bladder cancer cells to release extracellular vesicles that promote non-malignant urothelial cell transformation.
    Sci Rep. 2023;13:142.
    Abstract     Related articles   

  61. LI G, Wu S, Chen W, Duan X, et al
    Designing Intelligent Nanomaterials to Achieve Highly Sensitive Diagnoses and Multimodality Therapy of Bladder Cancer.
    Small Methods. 2023 Jan 4:e2201313. doi: 10.1002/smtd.202201313.
    Abstract     Related articles   

  62. DAWID DE VERA MT, Prieto Cuadra JD, Alvarez Perez M, Garrido-Aranda A, et al
    PD-L1 immunoexpression and molecular characterization of histological subtypes in urothelial carcinoma.
    Rev Esp Patol. 2023;56:10-20.
    Abstract     Related articles   

  63. ZHANG Y, Wang Z, Yang X, Zhao Q, et al
    The influence of serum sodium concentration on prognosis in patients with urothelial carcinoma treated by radical cystectomy.
    Medicine (Baltimore). 2022;101:e31973.
    Abstract     Related articles   

  64. SHIBATA T, Takata E, Sakamoto J, Shioya A, et al
    A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin (BCG-CWS) for cervical cancer.
    Medicine (Baltimore). 2022;101:e32481.
    Abstract     Related articles   

  65. XIANG X, Guo Y, Chen Z, Zhang F, et al
    A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
    Medicine (Baltimore). 2022;101:e32558.
    Abstract     Related articles   

  66. FENG F, Zhong YX, Huang JH, Lin FX, et al
    Identifying stage-associated hub genes in bladder cancer via weighted gene co-expression network and robust rank aggregation analyses.
    Medicine (Baltimore). 2022;101:e32318.
    Abstract     Related articles   

  67. CHHAYA S, Watts I, Ng K, Mustapha R, et al
    Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer.
    Oncol Ther. 2023 Jan 3. doi: 10.1007/s40487-022-00218.
    Abstract     Related articles   

  68. MONTEIRO-REIS S, Miranda-Goncalves V, Guimaraes-Teixeira C, Martins-Lima C, et al
    Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
    Int J Biol Sci. 2023;19:1-12.
    Abstract     Related articles   

  69. SHIMIZU T, Kobayashi Y, Fujiyoshi K, Yato Y, et al
    Tuberculous spondylitis following intravesical Bacillus Calmette-Guerin therapy for bladder cancer surgically treated through the anterior approach.
    BMJ Case Rep. 2022;15:e251075.
    Abstract     Related articles   

  70. SAPONARO M, Flottmann S, Eckstein M, Hommerding O, et al
    CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression.
    Sci Rep. 2023;13:73.
    Abstract     Related articles   

  71. ICHIHASI A, Inamoto T, Uchimoto T, Nakamura KO, et al
    Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
    In Vivo. 2023;37:143-148.
    Abstract     Related articles   

  72. SOOROJEBALLY Y, Neuzillet Y, Roumiguie M, Lamy PJ, et al
    Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
    World J Urol. 2023 Jan 2. doi: 10.1007/s00345-022-04253.
    Abstract     Related articles   

  73. CHEN Z, Qin C, Wang G, Shang D, et al
    A tumor microenvironment preoperative nomogram for prediction of lymph node metastasis in bladder cancer.
    Front Oncol. 2022;12:1099965.
    Abstract     Related articles   

  74. NONATO MB, Moraes RS, Bandeira Herenio YM, Nunes TF, et al
    Management of a Giant Urinary Bladder Clot with Intravesical Thrombolysis.
    J Vasc Interv Radiol. 2023;34:154-155.
    Abstract     Related articles   

  75. CHENG W, Zhou Y, Chu X, Huang S, et al
    Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis.
    Actas Urol Esp (Engl Ed). 2022 Dec 28:S2173-5786(22)00142.
    Abstract     Related articles   

  76. YAMASHITA T, Higashi M, Sugiyama H, Morozumi M, et al
    Cancer antigen 125 expression enhances the gemcitabine/cisplatin-resistant tumor microenvironment in bladder cancer.
    Am J Pathol. 2022 Dec 28:S0002-9440(22)00419.
    Abstract     Related articles   

  77. ZHOU M, Yang B, Zhou S, Yu P, et al
    Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis.
    J Cancer Res Clin Oncol. 2022 Dec 31. doi: 10.1007/s00432-022-04564.
    Abstract     Related articles   

  78. NISHIMURA N, Miyake M, Miyamoto T, Tomizawa M, et al
    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
    Jpn J Clin Oncol. 2022 Dec 30:hyac203. doi: 10.1093.
    Abstract     Related articles   

  79. XU Y, Tong Y, Lei Z, Zhu J, et al
    Abietic acid induces ferroptosis via the activation of the HO-1 pathway in bladder cancer cells.
    Biomed Pharmacother. 2022;158:114154.
    Abstract     Related articles   

  80. VAN DER FELS CAM, Leliveld A, Buikema H, van den Heuvel MC, et al
    VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder.
    BMC Urol. 2022;22:213.
    Abstract     Related articles   

  81. LEVY JJ, Liu X, Marotti JD, Kerr DA, et al
    Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique.
    Cancer Cytopathol. 2023;131:19-29.
    Abstract     Related articles   

  82. TANG L, Wang S, Wang Y, Li K, et al
    LncRNA-UCA1 regulates lung adenocarcinoma progression through competitive binding to miR-383.
    Cell Cycle. 2023;22:213-228.
    Abstract     Related articles   

  83. SASAKI Y, Takahashi M, Hashimoto K, Fukuta K, et al
    Efficacy of the Mercedes-Benz closure technique for vaginal reconstruction in female robot-assisted radical cystectomy.
    Asian J Endosc Surg. 2023;16:23-27.
    Abstract     Related articles   

  84. NAYA Y, Takaha N, Hayashi I, Mori M, et al
    Preliminary study of the safety of acrinol in probe-based confocal laser endomicroscopy during transurethral resection of bladder tumors.
    Asian J Endosc Surg. 2023;16:143-146.
    Abstract     Related articles   

  85. GARCIA JH, Morshed RA, Chung J, Millares Chavez MA, et al
    Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
    J Neurosurg. 2022 Apr 29:1-8. doi: 10.3171/2022.3.JNS212285.
    Abstract     Related articles   

  86. MAIBOM SL, Joensen UN, Aasvang EK, Rohrsted M, et al
    Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit for bladder cancer in an ERAS setup (BORARC): protocol for a single-centre, double-blinded, randomised feasibi
    Pilot Feasibility Stud. 2023;9:7.
    Abstract     Related articles   

  87. CHEN CC, Fa YC, Kuo YY, Liu YC, et al
    Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer.
    Adv Sci (Weinh). 2023 Jan 13:e2204643. doi: 10.1002/advs.202204643.
    Abstract     Related articles   

  88. LIU B, Su J, Fan B, Ni X, et al
    High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma.
    Medicine (Baltimore). 2023;102:e32667.
    Abstract     Related articles   

  89. MORIBATA Y, Kurata Y, Nishio M, Kido A, et al
    Automatic segmentation of bladder cancer on MRI using a convolutional neural network and reproducibility of radiomics features: a two-center study.
    Sci Rep. 2023;13:628.
    Abstract     Related articles   

  90. DOHERTY N, Cardwell CR, Murchie P, Hill C, et al
    5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 12:EPI-22-1109.
    Abstract     Related articles   

  91. LIU C, Wang XL, Shen EC, Wang BZ, et al
    Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer.
    Transl Androl Urol. 2022;11:1715-1728.
    Abstract     Related articles   

  92. TOMIYAMA E, Fujita K, Hashimoto M, Adomi S, et al
    Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review.
    Transl Androl Urol. 2022;11:1747-1761.
    Abstract     Related articles   

  93. JIA C, Zhang X, Qu T, Wu X, et al
    Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
    PeerJ. 2023;11:e14654.
    Abstract     Related articles   

  94. RIVEROS C, Chalfant V, Elshafei A, Bandyk M, et al
    Does care fragmentation in patients with bladder cancer lead to worse outcomes?
    Urol Oncol. 2023 Jan 9:S1078-1439(22)00432-X. doi: 10.1016/j.urolonc.2022.
    Abstract     Related articles   

  95. AFFERI L, Gallioli A, Del Giudice F, Pradere B, et al
    Comment on "Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis" on behalf of the Young Academic Urologists - Urothelial Cancer Working Group.
    Minerva Urol Nephrol. 2022;74:813-815.
    Abstract     Related articles   

  96. LIM S, Park JH, Chang H
    Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model.
    Investig Clin Urol. 2023;64:74-81.
    Abstract     Related articles   

  97. MEHTA P, Sinha S, Kashid S, Chakraborty D, et al
    Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Nov 18:S1558-7673(22)00241.
    Abstract     Related articles   

  98. HARA S, Honda M, Kawaharada A, Nakazono M, et al
    [A Case of Metastatic Ureteral Cancer Treated with Pembrolizumab without Relapse of Ocular Myasthenia Gravis].
    Hinyokika Kiyo. 2022;68:377-383.
    Abstract     Related articles   

  99. BAMIAS A, Merseburger A, Loriot Y, James N, et al
    New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.
    J Immunother Cancer. 2023;11:e005977.
    Abstract     Related articles   

  100. WEI X, Wang B, Wu Z, Yang X, et al
    WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity.
    Cancer Lett. 2023 Jan 7:216058. doi: 10.1016/j.canlet.2023.216058.
    Abstract     Related articles   

  101. ZHOU H, Huang J, Wang F
    Increased transcription of hsa_circ_0000644 upon RUNX family transcription factor 3 downregulation participates in the malignant development of bladder cancer.
    Cell Signal. 2023 Jan 7:110590. doi: 10.1016/j.cellsig.2023.110590.
    Abstract     Related articles   

  102. YU ZY, Yan L, Wang HK, Hang G, et al
    Bladder triangle amyloidosis: A case report and literature review.
    Medicine (Baltimore). 2022;101:e32179.
    Abstract     Related articles   

  103. AIZAT SABRI I, Yusof MR, Jagwani AV, Fahmy O, et al
    [A rare case of bladder leiomyoma in pregnancy: a case report].
    Urologiia. 2022;:118-121.
    Abstract     Related articles   

  104. LIMA NF JR, Sampaio LAF, Xavier CB, Mattedi RL, et al
    Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.
    JCO Precis Oncol. 2023;7:e2200414.
    Abstract     Related articles   

  105. FEIERTAG N, Barry E, Abramson M, Park JY, et al
    Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00262.
    Abstract     Related articles   

  106. WANG W, Hua S, Li J, Zhao J, et al
    Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature.
    Front Oncol. 2022;12:1081091.
    Abstract     Related articles   

  107. SHI C, Zhang L, Chen D, Wei H, et al
    Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer.
    Front Immunol. 2022;13:1054157.
    Abstract     Related articles   

  108. MOUSA FA, Jasim HA, Shakir F
    A Prognostic Impact of Interleukin 17 (IL-17) as an Immune-Marker in Patients with Bladder Cancer.
    Arch Razi Inst. 2022;77:1059-1065.
    Abstract     Related articles   

  109. ZHU Y, Zuo L, Xiong H, Li S, et al
    CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Cell Cycle. 2023 Jan 8:1-20. doi: 10.1080/15384101.2022.2164454.
    Abstract     Related articles   

  110. SPAGNUOLO C, Moccia S, Tedesco I, Crescente G, et al
    Phenolic Extract from Extra Virgin Olive Oil Induces Different Anti-Proliferative Pathways in Human Bladder Cancer Cell Lines.
    Nutrients. 2022;15:182.
    Abstract     Related articles   

  111. LI Z, Qi N, Gao Z, Ding L, et al
    How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience.
    J Clin Med. 2022;12:169.
    Abstract     Related articles   

  112. KUO MY, Yang WT, Ho YJ, Chang GM, et al
    Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines.
    Int J Mol Sci. 2022;24:138.
    Abstract     Related articles   

  113. DOMINGOS-PEREIRA S, Sathiyanadan K, Polak L, Haefliger JA, et al
    Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
    Int J Mol Sci. 2022;24:123.
    Abstract     Related articles   

  114. GOUTAS D, Palamaris K, Stofas A, Politakis N, et al
    Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression.
    Cancers (Basel). 2022;15:188.
    Abstract     Related articles   

  115. MIYAGI H, Kwenda E, Ramnaraign BH, Chatzkel JA, et al
    Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2022;15:168.
    Abstract     Related articles   

  116. ZHANG W, Yang F, Zheng Z, Li C, et al
    Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer.
    Cancers (Basel). 2022;15:131.
    Abstract     Related articles   

  117. SMITH V, Mukherjee D, Tsakiroglou AM, Baker A, et al
    Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2022;15:41.
    Abstract     Related articles   

  118. GWON YN, Park JJ, Lee KS, Lee KH, et al
    Microbiome in Bladder Cancer: A Systematic Review.
    Diagnostics (Basel). 2022;13:84.
    Abstract     Related articles   

  119. CHEN S, Jian Y, Tang W, Gu H, et al
    Replacement of long-segment ureteral defect with tapered demucosalized ileum: medium-term outcomes of 4 patients.
    BMC Urol. 2023;23:7.
    Abstract     Related articles   

  120. LI W, Cheng M, Hu P, Jiang L, et al
    Prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis.
    Sci Rep. 2023;13:283.
    Abstract     Related articles   

  121. TIAN C, Liu J, An L, Hong Y, et al
    Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study.
    BMC Urol. 2023;23:2.
    Abstract     Related articles   

  122. MASONE MC
    The prognostic role of stroma in UTUC.
    Nat Rev Urol. 2023;20:7.
    Abstract     Related articles   

  123. MASONE MC
    A non-invasive assay for UTUC diagnosis.
    Nat Rev Urol. 2023;20:8.
    Abstract     Related articles   

  124. KOTERAZAWA S, Kanno T, Kobori G, Ito K, et al
    Clinical outcomes following laparoscopic radical nephroureterectomy in octogenarians.
    Int J Clin Oncol. 2023;28:155-162.
    Abstract     Related articles   

  125. YU SL, Hsiao YJ, Cooper WA, Choi YL, et al
    The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer.
    Pathology. 2023;55:19-30.
    Abstract     Related articles   

  126. TOMITA Y, Kobayashi K, Kimura G, Oya M, et al
    Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
    Jpn J Clin Oncol. 2023;53:16-25.
    Abstract     Related articles   

  127. LENNARTZ M, Ullmann VS, Gorbokon N, Uhlig R, et al
    Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
    APMIS. 2023;131:77-91.
    Abstract     Related articles   

  128. HOLMES A, O'Kane D, Wombwell A, Grills R, et al
    Clinical Utility of a Single-Use Flexible Cystoscope Compared with a Standard Reusable Device: A Randomized Noninferiority Study.
    J Endourol. 2023;37:80-84.
    Abstract     Related articles   

  129. NAKAGAWA T, Shigehara K, Kato Y, Kawaguchi S, et al
    Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples.
    J Med Virol. 2023;95:e28110.
    Abstract     Related articles   

  130. PENDELA VS, Said B, Kudaravalli P, Chhabria M, et al
    Interstitial Pneumonitis-A Newly Recognized Consequence of Intravesical Gemcitabine Therapy.
    Am J Ther. 2022;29:e752-e754.
    Abstract     Related articles   

  131. LIN W, Pan X, Zhang C, Ye B, et al
    Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance, Epidemiology, and End Results-Based Study 2004-2015.
    Cancer Control. 2023;30:10732748231152322.
    Abstract     Related articles   

  132. YUKSEL O, Tosun C, Gumrukcu G, Tokuc E, et al
    What is the role of CellDetect((R)) in detecting and monitoring bladder cancer?
    Urologia. 2023 Jan 20:3915603221150036. doi: 10.1177/03915603221150036.
    Abstract     Related articles   

  133. WU J, Wang X, Xu H, Tian J, et al
    Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
    Ann Transl Med. 2022;10:1386.
    Abstract     Related articles   

  134. NAGATA M, Ishizaka K, Asano T
    CD169(+) Macrophages Residing in the Draining Lymph Nodes and Infiltrating the Tumor Play Opposite Roles in the Pathogenesis of Bladder Cancer.
    Res Rep Urol. 2023;15:1-7.
    Abstract     Related articles   

  135. WARLI SM, Prapiska FF, Siregar DIS, Wijaya WS, et al
    Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients.
    World J Oncol. 2022;13:365-369.
    Abstract     Related articles   

  136. CHAUHAN PS, Shiang A, Alahi I, Sundby RT, et al
    Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.
    NPJ Precis Oncol. 2023;7:6.
    Abstract     Related articles   

  137. BAXTER L, Gordon NS, Ott S, Wang J, et al
    Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection.
    Sci Rep. 2023;13:1060.
    Abstract     Related articles   

  138. WU X, Xu Q, Li T, Wei Y, et al
    Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Appl Biochem Biotechnol. 2023 Jan 19. doi: 10.1007/s12010-022-04295.
    Abstract     Related articles   

  139. ZHANG W, Zhou B, Deng J, Han G, et al
    Retrospective analysis of 1470-/980-nm dual-wavelength laser en bloc resection versus transurethral resection of bladder tumor for primary non-muscle-invasive bladder cancer.
    Lasers Med Sci. 2023;38:44.
    Abstract     Related articles   

  140. YADAV K, Agarwal P, Kumar M, Gupta S, et al
    Immunohistochemical appraisal of epithelial mesenchymal transition type III in gall bladder cancer.
    Indian J Pathol Microbiol. 2023;66:44-53.
    Abstract     Related articles   

  141. WANG S, Yu Z, Du P, Cao Y, et al
    Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: A retrospectively clinical study.
    Asia Pac J Clin Oncol. 2023 Jan 19. doi: 10.1111/ajco.13931.
    Abstract     Related articles   

  142. GROBET-JEANDIN E, Pinar U, Parra J, Roupret M, et al
    Health-related quality of life after curative treatment for muscle-invasive bladder cancer.
    Nat Rev Urol. 2023 Jan 18. doi: 10.1038/s41585-022-00693.
    Abstract     Related articles   

  143. FU X, Yu G, Guo Y
    [Expression pattern of the histone lysine demethylase family and its potential role in bladder cancer: a multi-omics analysis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1822-1831.
    Abstract     Related articles   

  144. SELIM MS, Kassem AB, El-Bassiouny NA, Salahuddin A, et al
    Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.
    Med Oncol. 2023;40:80.
    Abstract     Related articles   

  145. WANG Y, Zhang W, Xiao W, Chen S, et al
    Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and Multidetector Computed Tomography.
    Tomography. 2022;9:25-35.
    Abstract     Related articles   

  146. RAMMANT E, Fox L, Beyer K, Aaronson NK, et al
    The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.
    Qual Life Res. 2023 Jan 17. doi: 10.1007/s11136-022-03335.
    Abstract     Related articles   

  147. RUBIN R
    New Gene Therapy for Certain Bladder Cancers.
    JAMA. 2023;329:201.
    Abstract     Related articles   

  148. GU J, He Z, Chen Z, Wu H, et al
    Efficacy and safety of 2-micron laser versus conventional trans-urethral resection of bladder tumor for non-muscle-invasive bladder tumor: A systematic review and meta-analysis.
    J Cancer Res Ther. 2022;18:1894-1902.
    Abstract     Related articles   

  149. JI J, Yao Y, Guan F, Sun L, et al
    Efficacy and adverse reactions of intra-arterial chemotherapy in patients with bladder cancer: A systematic review and meta-analysis.
    J Cancer Res Ther. 2022;18:1884-1893.
    Abstract     Related articles   

  150. RAADABADI M, Daroudi R, Zendehdel K, Haghdoost AA, et al
    Direct and indirect medical costs of bladder cancer in Iran.
    Cost Eff Resour Alloc. 2023;21:5.
    Abstract     Related articles   

  151. LUO M, Zhang Y, Xu Z, Lv S, et al
    Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation.
    Mol Med. 2023;29:7.
    Abstract     Related articles   

  152. CARVALHO LB, Capelo JL, Lodeiro C, Dhir R, et al
    Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics.
    Commun Med (Lond). 2023;3:8.
    Abstract     Related articles   

  153. SECHER MS, Hyldgaard J, Jensen JB
    The association between gender, stage and prognosis in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2023 Jan 16:1-5. doi: 10.1080/21681805.2023.2166103.
    Abstract     Related articles   

  154. LIU W, Xu Y, Bai S, Liao L, et al
    Bioinformatics analysis of key biomarkers for bladder cancer.
    Biomed Rep. 2022;18:14.
    Abstract     Related articles   

  155. VILLANUEVA H, Wells GA, Miller MT, Villanueva M, et al
    Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model.
    Heliyon. 2022;8:e12570.
    Abstract     Related articles   

  156. SHEFER HK, Masarwe I, Bejar J, Naamnih LH, et al
    Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion.
    Urol Oncol. 2023 Jan 13:S1078-1439(22)00497.
    Abstract     Related articles   

  157. GOEBELL PJ, Kamat AM, Black PC, Dyrskjot L, et al
    Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updates.
    Urol Oncol. 2023 Jan 12:S1078-1439(22)00498.
    Abstract     Related articles   

  158. WU Q, Chen P, Li J, Lin Z, et al
    Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin alpha5/beta1-FAK/Src axis: A novel strategy for drug application.
    Pharmacol Res. 2023;188:106654.
    Abstract     Related articles   

  159. WU J, Jin S, Gu C, Wei Y, et al
    Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
    Cell Rep Med. 2023;4:100883.
    Abstract     Related articles   

  160. ORSI DL, Ferrara SJ, Siegel S, Friberg A, et al
    Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.
    Bioorg Med Chem. 2022;78:117130.
    Abstract     Related articles   

  161. KUJDOWICZ M, Perez-Guaita D, Chlosta P, Okon K, et al
    Evaluation of grade and invasiveness of bladder urothelial carcinoma using infrared imaging and machine learning.
    Analyst. 2022 Dec 16. doi: 10.1039/d2an01583.
    Abstract     Related articles   

  162. PETTITT GA, Hurst CD, Khan Z, McPherson HR, et al
    Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro.
    J Pathol. 2023;259:220-232.
    Abstract     Related articles   

  163. HOGAN K, McKenney JK, Cox RM, Nguyen JK, et al
    Myxoid Pseudotumor Involving the Renal Sinus: Clinicopathologic Study of 33 Cases Supporting a Distinct Benign Non-neoplastic Lesion.
    Am J Surg Pathol. 2023;47:218-223.
    Abstract     Related articles   

  164. SHIMURA S, Matsumoto K, Ikeda M, Moroo S, et al
    A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence.
    Asia Pac J Clin Oncol. 2023;19:71-78.
    Abstract     Related articles   

  165. ZHANG W, Yang F, Mao S, Wang R, et al
    Bladder cancer-associated microbiota: Recent advances and future perspectives.
    Heliyon. 2023;9:e13012.
    Abstract     Related articles   

  166. ALJABERY F, Shabo I, Saudi A, Holmbom M, et al
    The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancer.
    Urol Oncol. 2023 Jan 24:S1078-1439(22)00490.
    Abstract     Related articles   

  167. HOGLUND M, Bernardo C, Sjodahl G, Eriksson P, et al
    The Lund Taxonomy for Bladder Cancer Classification - From Gene Expression Clustering to Cancer Cell Molecular Phenotypes, and Back Again.
    J Pathol. 2023 Jan 26. doi: 10.1002/path.6062.
    Abstract     Related articles   

  168. WAN B, Ma N, Lu W
    Mendelian randomization investigation identified the causal relationship between body fat indexes and the risk of bladder cancer.
    PeerJ. 2023;11:e14739.
    Abstract     Related articles   

  169. MARTINS-LIMA C, Chianese U, Benedetti R, Altucci L, et al
    Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
    Front Mol Biosci. 2023;9:1070383.
    Abstract     Related articles   

  170. LI P, Mi Q, Yan S, Xie Y, et al
    Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-beta2 signaling axis.
    Cell Death Dis. 2023;14:59.
    Abstract     Related articles   

  171. YONG Z, Ang L, Wen-Zhang Z, Xu-Dong W, et al
    Incidental gall bladder cancer in the laparoscopic treatment and magnetic resonance imaging era: A single institution experience.
    J Minim Access Surg. 2023 Jan 9. doi: 10.4103.
    Abstract     Related articles   

  172. VAN PUFFELEN JH, Novakovic B, van Emst L, Kooper D, et al
    Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    J Immunother Cancer. 2023;11:e005518.
    Abstract     Related articles   

  173. PAN J, Hong G, Zeng H, Liao C, et al
    An artificial intelligence model for the pathological diagnosis of invasion depth and histologic grade in bladder cancer.
    J Transl Med. 2023;21:42.
    Abstract     Related articles   

  174. JIN M, Lu S, Wu Y, Yang C, et al
    Retraction Note: Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    J Exp Clin Cancer Res. 2023;42:32.
    Abstract     Related articles   

  175. LIU HP, Jia W, Kadeerhan G, Xue B, et al
    Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature.
    Transl Oncol. 2023;29:101629.
    Abstract     Related articles   

  176. LAI AL, Law YM
    VI-RADS in bladder cancer: Overview, pearls and pitfalls.
    Eur J Radiol. 2023;160:110666.
    Abstract     Related articles   

  177. SHEN C, Yan Y, Yang S, Wang Z, et al
    Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Funct Integr Genomics. 2023;23:46.
    Abstract     Related articles   

  178. TALWAR HS, Panwar VK, Mittal A, Kishore S, et al
    A Clinicopathological Correlation of Bladder Cancer in Young and Old Patients: Our Experience and Review of Literature.
    Indian J Surg Oncol. 2022;13:915-923.
    Abstract     Related articles   

    Retracted: Effect of Radical Laparoscopic Surgery and Conventional Open Surgery on Surgical Outcomes, Complications, and Prognosis in Elderly Patients with Bladder Cancer.
    Evid Based Complement Alternat Med. 2023;2023:9835627.
    Abstract     Related articles   

  180. YU X, Luo B, Lin J, Zhu Y, et al
    Alternative splicing event associated with immunological features in bladder cancer.
    Front Oncol. 2023;12:966088.
    Abstract     Related articles   

  181. CAI J, Xie H, Yan Y, Huang Z, et al
    A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer.
    Front Genet. 2023;13:1082691.
    Abstract     Related articles   

  182. XIAO Y, Xu D, Jiang C, Huili Y, et al
    Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer.
    Front Genet. 2023;13:1087246.
    Abstract     Related articles   

  183. DENG H, Deng D, Qi T, Liu Z, et al
    An IFN-gamma-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts.
    Front Genet. 2023;13:1100317.
    Abstract     Related articles   

  184. TANTRAY I, Ojha R, Sharma AP
    Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer.
    Front Genet. 2023;13:1051762.
    Abstract     Related articles   

  185. ASHRAFIZADEH M, Zarrabi A, Karimi-Maleh H, Taheriazam A, et al
    (Nano)platforms in bladder cancer therapy: Challenges and opportunities.
    Bioeng Transl Med. 2022;8:e10353.
    Abstract     Related articles   

  186. HAN DS, Johnson JP, Schulster ML, Shah O, et al
    Indications for and results of renal autotransplantation.
    Curr Opin Nephrol Hypertens. 2023;32:183-192.
    Abstract     Related articles   

  187. TANABE T, Osawa T, Hotta K, Iwami D, et al
    Nihon Hinyokika Gakkai Zasshi. 2022;113:37-41.
    Abstract     Related articles   

  188. IMAMURA T, Miyachi S, Horiuchi E, Ikeda T, et al
    Nihon Hinyokika Gakkai Zasshi. 2022;113:28-32.
    Abstract     Related articles   

  189. KONDO Y, Takayama T
    Nihon Hinyokika Gakkai Zasshi. 2022;113:12-15.
    Abstract     Related articles   

  190. EL-MAHDY HA, Elsakka EGE, El-Husseiny AA, Ismail A, et al
    miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review.
    Pathol Res Pract. 2023;242:154316.
    Abstract     Related articles   

  191. KOBAYASHI K, Matsuyama H, Oka S, Nakamura K, et al
    Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Photodiagnosis Photodyn Ther. 2023;41:103294.
    Abstract     Related articles   

  192. YU C, Wang S, Lai WF, Zhang D, et al
    The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment.
    Pharmaceutics. 2023;15:211.
    Abstract     Related articles   

  193. RU R, Chen G, Liang X, Cao X, et al
    Sea Cucumber Derived Triterpenoid Glycoside Frondoside A: A Potential Anti-Bladder Cancer Drug.
    Nutrients. 2023;15:378.
    Abstract     Related articles   

  194. NIKIC P, Dragicevic D, Jerotic D, Savic S, et al
    Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness.
    Medicina (Kaunas). 2023;59:131.
    Abstract     Related articles   

  195. TRIFANESCU OG, Gales LN, Paun MA, Motas N, et al
    Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
    Medicina (Kaunas). 2022;59:50.
    Abstract     Related articles   

  196. YI L, Ai K, Li X, Li Z, et al
    Bone Metastasis in Bladder Cancer.
    J Pers Med. 2022;13:54.
    Abstract     Related articles   

  197. CABALLERO JM, Gili JM, Pereira JC, Gomariz A, et al
    Risk Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain: A Case-Control Study.
    J Clin Med. 2023;12:728.
    Abstract     Related articles   

  198. YANG S, Zhou H, Feng C, Xu N, et al
    Web-Based Nomograms for Overall Survival and Cancer-Specific Survival of Bladder Cancer Patients with Bone Metastasis: A Retrospective Cohort Study from SEER Database.
    J Clin Med. 2023;12:726.
    Abstract     Related articles   

  199. HUANG GK, Huang CC, Kang CH, Cheng YT, et al
    Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity.
    Int J Mol Sci. 2023;24:1776.
    Abstract     Related articles   

  200. LAZEWSKI D, Kucinska M, Potapskiy E, Kuzminska J, et al
    Enhanced Cytotoxic Activity of PEGylated Curcumin Derivatives: Synthesis, Structure-Activity Evaluation, and Biological Activity.
    Int J Mol Sci. 2023;24:1467.
    Abstract     Related articles   

  201. PEREZ-MONTIEL MD, Cerrato-Izaguirre D, Sanchez-Perez Y, Diaz-Chavez J, et al
    Mutational Landscape of Bladder Cancer in Mexican Patients: KMT2D Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion.
    Int J Mol Sci. 2023;24:1092.
    Abstract     Related articles   

  202. DAS S, Hayden J, Sullivan T, Rieger-Christ K, et al
    The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment.
    Int J Mol Sci. 2023;24:964.
    Abstract     Related articles   

  203. VARELA M, Lopez M, Ingold M, Alem D, et al
    New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.
    Biomedicines. 2023;11:199.
    Abstract     Related articles   

  204. BEJRANANDA T, Saetang J, Sangkhathat S
    Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment.
    Biomedicines. 2022;11:69.
    Abstract     Related articles   

  205. MONTEIRO-REIS S, Ferreira JPS, Pires RA, Lobo J, et al
    Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study.
    Cancers (Basel). 2023;15:359.
    Abstract     Related articles   

  206. SONG FX, Xu X, Ding H, Yu L, et al
    Recent Progress in Nanomaterial-Based Biosensors and Theranostic Nanomedicine for Bladder Cancer.
    Biosensors (Basel). 2023;13:106.
    Abstract     Related articles   

  207. ZHANG Q, Liu S, Wang H, Xiao K, et al
    ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer.
    Adv Sci (Weinh). 2023 Jan 20:e2205613. doi: 10.1002/advs.202205613.
    Abstract     Related articles   

  208. BEIJERT IJ, Hentschel AE, Brundl J, Comperat EM, et al
    Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
    Eur Urol Oncol. 2023 Jan 18:S2588-9311(23)00004.
    Abstract     Related articles   

  209. YEN A, Shen C, Albuquerque K
    The New Kid on the Block: Online Adaptive Radiotherapy in the Treatment of Gynecologic Cancers.
    Curr Oncol. 2023;30:865-874.
    Abstract     Related articles   

  210. ZALAY O, Yan M, Sigurdson S, Malone S, et al
    Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.
    Curr Oncol. 2022;30:19-36.
    Abstract     Related articles   

  211. PATWARDHAN PP, Quiroga-Garza GM
    Extramammary paget disease of the penoscrotal region.
    Pathol Res Pract. 2023;241:154283.
    Abstract     Related articles   

  212. KANG SY, Heo YJ, Kwon GY, Lee J, et al
    Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomas.
    Pathol Res Pract. 2023;241:154233.
    Abstract     Related articles   

  213. MLICKA A, Mlicki P, Niewiadomski P, Zielinska W, et al
    Synergistic effect of metformin and doxorubicin on the metastatic potential of T24 cells.
    Acta Histochem. 2023;125:151975.
    Abstract     Related articles   

  214. HEROUT R, Baunacke M, Flegar L, Borkowetz A, et al
    Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019.
    World J Urol. 2023;41:127-133.
    Abstract     Related articles   

  215. GUO B, Wang Y, Liu W, Zhang S, et al
    Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Clin Transl Oncol. 2023;25:535-554.
    Abstract     Related articles   

  216. HUANG L, Shao W, Wang X, Li F, et al
    TBX3 stimulates proliferation and stem cell self-renewal in bladder carcinoma.
    Histol Histopathol. 2023;38:65-72.
    Abstract     Related articles   

  217. KULLMANN F, Strissel PL, Strick R, Stoehr R, et al
    Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.
    J Clin Pathol. 2023;76:126-132.
    Abstract     Related articles   

  218. XIANG L, Zeng Q, Liu J, Xiao M, et al
    MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis.
    Sci Bull (Beijing). 2021;66:1773-1788.
    Abstract     Related articles   

  219. KLEANTHOUS K, Alexopoulou E, Papadopoulos I, Mazioti A, et al
    Asymptomatic bladder neurofibroma in neurofibromatosis type I.
    Minerva Pediatr (Torino). 2022;74:799-801.
    Abstract     Related articles   

  220. QIU M, Yu L, Liang J, Xia J, et al
    Aloperine Prevents Migration, Invasion, and Adhesion by Upregulating TIMP-4 in Human Bladder Cancer Cells.
    Protein Pept Lett. 2023 Jan 24. doi: 10.2174/0929866530666230124112754.
    Abstract     Related articles   

  221. WANG Q, Li B, Zhang W, Li Z, et al
    Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells.
    Front Chem. 2023;11:1121724.
    Abstract     Related articles   

  222. WU K, Jiang D, Zhang L, Jiang S, et al
    Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial.
    Front Oncol. 2023;12:1065735.
    Abstract     Related articles   

  223. LIU L, Li C, Wang Q, Yuan H, et al
    A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.
    Eur J Med Res. 2023;28:61.
    Abstract     Related articles   

  224. LI DX, Feng DC, Wang XM, Wu RC, et al
    M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients.
    Eur J Med Res. 2023;28:55.
    Abstract     Related articles   

  225. MORENO-FONTELA MP, Pinazo-Rubio I, Garrido-Abad P
    Penoscrotal oedema as the first sign of metastatic urothelial bladder cancer.
    BMJ Case Rep. 2023;16:e254106.
    Abstract     Related articles   

  226. AGGARWAL A, Goel S, Sayed AI, Goel V, et al
    Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease?
    J Gastrointest Cancer. 2023 Feb 2. doi: 10.1007/s12029-023-00914.
    Abstract     Related articles   

  227. LI Q, Luo Y, Liu D, Li B, et al
    Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm.
    Front Oncol. 2023;12:966506.
    Abstract     Related articles   

  228. WANG W, Huang G, Lin H, Ren L, et al
    Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
    Front Oncol. 2023;12:1102392.
    Abstract     Related articles   

  229. TAAFFE DR, McCombie SP, Galvao DA, Newton RU, et al
    Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy.
    Med Sci Sports Exerc. 2023 Feb 2. doi: 10.1249/MSS.0000000000003137.
    Abstract     Related articles   

  230. PATEL SA, Liu Y, Solanki AA, Baumann BC, et al
    Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
    Urol Oncol. 2023 Jan 30:S1078-1439(22)00494.
    Abstract     Related articles   

  231. Correction: Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    J Immunother Cancer. 2023;11:e005518corr1.
    Abstract     Related articles   

  232. GETZ K, Hubbard RA, Linn KA
    Performance of Multiple Imputation Using Modern Machine Learning Methods in Electronic Health Records Data.
    Epidemiology. 2023;34:206-215.
    Abstract     Related articles   

  233. CHALFANT V, Blute ML Jr, Silberstein P
    Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013.
    Asian J Urol. 2023;10:9-18.
    Abstract     Related articles   

  234. ZHANG Y, Zhang X, Huang X, Tang X, et al
    Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
    Stem Cell Res Ther. 2023;14:15.
    Abstract     Related articles   

  235. KATLEBA KD, Tsamouri MM, Jathal M, Baek HB, et al
    Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells.
    Sci Rep. 2023;13:1762.
    Abstract     Related articles   

  236. CHEONG JK, Ooi EH, Chiew YS, Menichetti L, et al
    Gold nanorods assisted photothermal therapy of bladder cancer in mice: A computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer.
    Comput Methods Programs Biomed. 2023;230:107363.
    Abstract     Related articles   

  237. WANG K, Wang G, Li G, Zhang W, et al
    m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
    Apoptosis. 2023 Jan 31. doi: 10.1007/s10495-023-01817.
    Abstract     Related articles   

  238. WU D, Lin J, Zhu Y, Zhang H, et al
    Retracted: Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Med Sci Monit. 2023;29:e939596.
    Abstract     Related articles   

  239. ZAHIRI E, Ghorbani H, Moradi A, Mehrad-Majd H, et al
    Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer.
    Rep Biochem Mol Biol. 2022;11:411-420.
    Abstract     Related articles   

  240. DONG S, Zheng L, Jiang T
    Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell Line.
    J Oncol. 2023;2023:2830306.
    Abstract     Related articles   

  241. CHEN W, Tan M, Yu C, Liao G, et al
    ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via beta-catenin signaling and enhances mitomycin C sensitivity.
    Hum Cell. 2023 Jan 30. doi: 10.1007/s13577-023-00860.
    Abstract     Related articles   

  242. CHEN T, Shi S, Zheng P, Zhan X, et al
    Predictive nomograms for early death in metastatic bladder cancer.
    Front Surg. 2023;9:1037203.
    Abstract     Related articles   

  243. WANG C, Jin W, Ma X, Dong Z, et al
    The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia.
    Front Oncol. 2023;12:1101830.
    Abstract     Related articles   

  244. LIU T, Li S, Xia C, Xu D, et al
    TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.
    Front Immunol. 2023;13:1071390.
    Abstract     Related articles   

  245. DING L, Deng X, Wang K, Xia W, et al
    Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer.
    J Inflamm Res. 2023;16:283-296.
    Abstract     Related articles   

  246. MAKRAKIS D, Wright JL, Roudier MP, Garcia J, et al
    A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Dec 23:S1558-7673(22)00261.
    Abstract     Related articles   

  247. JIANG S, Zhang J, Fan Q, Li Z, et al
    A prognostic cuproptosis-related lncRNA predictive signature for bladder cancer patients.
    Hum Cell. 2023 Jan 29. doi: 10.1007/s13577-023-00863.
    Abstract     Related articles   

  248. MATHUR P, De Barros Santos C, Lachuer H, Patat J, et al
    Transcription factor EB regulates phosphatidylinositol-3-phosphate levels that control lysosome positioning in the bladder cancer model.
    Commun Biol. 2023;6:114.
    Abstract     Related articles   

  249. WANG Z, Huang Z, Cao X, Zhang F, et al
    A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
    BMC Urol. 2023;23:10.
    Abstract     Related articles   

  250. JING S, Feng Y, He XL, Wang Y, et al
    [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].
    Zhonghua Zhong Liu Za Zhi. 2023;45:56-63.
    Abstract     Related articles   

  251. ABDEL-HAFIZ SM, Sherif H, Romeih M, Elesaily K, et al
    Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer.
    Asian Pac J Cancer Prev. 2023;24:121-131.
    Abstract     Related articles   

  252. TAHERI D, Jahanshahi F, Khajavi A, Kafi F, et al
    The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
    Clin Genitourin Cancer. 2023;21:84-90.
    Abstract     Related articles   

  253. CHAWLA NS, Sayegh N, Tripathi N, Govindarajan A, et al
    Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:69-75.
    Abstract     Related articles   

  254. LIN Y, Lin L, Yang Y, Li M, et al
    DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2023;21:32-42.
    Abstract     Related articles   

  255. LIN D, Luo S, Lin S, Zhong L, et al
    Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma-A Cost-Effectiveness Analysis.
    Clin Genitourin Cancer. 2023;21:8-15.
    Abstract     Related articles   

  256. UMEDA K, Tanaka N, Yasumizu Y, Takeda T, et al
    Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab.
    Clin Genitourin Cancer. 2023;21:128-135.
    Abstract     Related articles   

  257. ISHIHARA H, Ishiyama Y, Nemoto Y, Nakamura K, et al
    Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
    Clin Genitourin Cancer. 2023;21:136-145.
    Abstract     Related articles   

  258. DARIANE C, Timsit MO
    DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Eur Surg Res. 2022;63:155-164.
    Abstract     Related articles   

  259. AVULOVA S, Benidir T, Cheville JC, Packiam VT, et al
    Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.
    Arch Pathol Lab Med. 2023;147:202-207.
    Abstract     Related articles   

  260. TU Y, Mao Z
    Identification and validation of molecular subtype and prognostic signature for bladder cancer based on neutrophil extracellular traps.
    Cancer Invest. 2023 Feb 10:1-12. doi: 10.1080/07357907.2023.2179063.
    Abstract     Related articles   

  261. TOMINAGA Y, Fujii M, Sadahira T, Katayama S, et al
    Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guerin therapy for urinary bladder cancer: A case report.
    Mol Clin Oncol. 2022;18:7.
    Abstract     Related articles   

  262. MITTAL S, Malik K, Raja A
    Nonbilharzial Squamous Cell Bladder Cancer: An Indian Experience.
    South Asian J Cancer. 2022;11:322-325.
    Abstract     Related articles   

  263. BRUMMELHUIS ISG, Crezee J, Witjes JA
    Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
    Int J Hyperthermia. 2023;40:2157498.
    Abstract     Related articles   

  264. YIN L, Ying L, Guo R, Hao M, et al
    Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer Cells by NFkappaB1 and Mitochondria Pathway.
    Chem Biol Drug Des. 2023 Feb 8. doi: 10.1111/cbdd.14207.
    Abstract     Related articles   

  265. AL-MAGHRABI JA, Khabaz MN
    Clinical significance of galectin-3 expression in urinary bladder carcinoma.
    J Int Med Res. 2023;51:3000605231153323.
    Abstract     Related articles   

  266. LV J, Li K, Yu H, Han J, et al
    HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    J Exp Clin Cancer Res. 2023;42:41.
    Abstract     Related articles   

  267. KESSLER ER, Schmiege SJ, Eguchi M, Singh S, et al
    Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis.
    Aging Cancer. 2022;3:105-115.
    Abstract     Related articles   

  268. CHEN Z, Chen D, Song Z, Lv Y, et al
    Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing.
    Front Oncol. 2023;12:1105026.
    Abstract     Related articles   

  269. WANG X, Zhang S, Jin D, Luo J, et al
    mu-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial.
    Cancer Commun (Lond). 2023 Feb 5. doi: 10.1002/cac2.12408.
    Abstract     Related articles   

  270. YANG K, Hu H, Wu J, Wang H, et al
    Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
    Mol Cancer. 2023;22:25.
    Abstract     Related articles   

  271. NI W, Yi L, Dong X, Cao M, et al
    PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Sci Rep. 2023;13:2051.
    Abstract     Related articles   

  272. TABAEI S, Haghshenas MR, Webster TJ, Ghaderi A, et al
    Proteomic strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources.
    Anal Biochem. 2023 Feb 2:115074. doi: 10.1016/j.ab.2023.115074.
    Abstract     Related articles   

  273. QUARESMA V, Marconi L, Jarimba R, Lima J, et al
    Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary Referral Center in Portugal.
    Acta Med Port. 2023;36:145-146.
    Abstract     Related articles   

  274. HELAL DS, Darwish SA, Awad RA, Ali DA, et al
    Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival.
    Diagn Pathol. 2023;18:11.
    Abstract     Related articles   

  275. COOPER OAE, Ghatnekar O, Piglowska N, Smith CA, et al
    Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC).
    Pharmacoecon Open. 2023 Feb 3. doi: 10.1007/s41669-023-00392.
    Abstract     Related articles   

  276. TISSOT G, Xylinas E
    Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder Cancer: The MK-3475-992/KEYNOTE-992 Trial.
    Eur Urol Focus. 2023 Feb 1:S2405-4569(22)00295-4. doi: 10.1016/j.euf.2022.
    Abstract     Related articles   

  277. REN S, Dai R, Zheng Z, Liu Q, et al
    A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer.
    Nanomedicine. 2023;49:102661.
    Abstract     Related articles   

  278. BUYUCEK S, Coskun SK, Onal B, Gamsizkan M, et al
    Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma.
    J Environ Pathol Toxicol Oncol. 2023;42:65-77.
    Abstract     Related articles   

  279. NAKASE T, Hata T, Ikeshima R, Kawai K, et al
    [A Case of Robotic-Assisted Surgery for Simultaneous Triple Cancer of Rectum, Bladder, and Prostate].
    Gan To Kagaku Ryoho. 2022;49:1676-1677.
    Abstract     Related articles   

  280. IZUTANI Y, Nakata K, Takayama H, Miyake Y, et al
    [Case of Robot-Assisted Low Anterior Resection with Total Cystectomy for Rectal Cancer Invading the Urinary Bladder/Prostate in Collaboration with Urologists].
    Gan To Kagaku Ryoho. 2022;49:1565-1567.
    Abstract     Related articles   

  281. KUSAFUKA H, Ikeshima R, Kawai K, Hiraki M, et al
    [A Case of Laparoscopic Surgery for Sigmoid Colon Cancer after Cystectomy and Ileal Conduit Construction].
    Gan To Kagaku Ryoho. 2022;49:1870-1872.
    Abstract     Related articles   

  282. QU F, Yan X, Yu W
    Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.
    Anticancer Drugs. 2023;34:317-324.
    Abstract     Related articles   

  283. ZHANG Q, Liang Y, Zhang Y, Tao Z, et al
    A comparative study of attention mechanism based deep learning methods for bladder tumor segmentation.
    Int J Med Inform. 2023;171:104984.
    Abstract     Related articles   

  284. HETTERICH J, Schmidt V, Herth M, Merhof K, et al
    Urothelial carcinoma in a Russian tortoise (Testudohorsfieldii).
    J Comp Pathol. 2023;200:18-22.
    Abstract     Related articles   

  285. TANAKA S, Naritomi M, Monobe Y, Ariyasu S, et al
    The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
    Cytopathology. 2023;34:106-112.
    Abstract     Related articles   

  286. DE KERVILER E, de Margerie-Mellon C, Dumont C, Pachev A, et al
    Salvage Percutaneous Cryoablation for Bleeding Upper Tract Urothelial Carcinoma.
    Cardiovasc Intervent Radiol. 2023;46:255-258.
    Abstract     Related articles   

  287. KOMAI Y, Nakajima K, Saito K, Tomioka Y, et al
    Development of a New Two-Arm Transurethral Surgical System for En Bloc Resection of Bladder Tumor: A Preclinical Study.
    J Endourol. 2023;37:165-170.
    Abstract     Related articles   

  288. DENG R, Zhang H, Li Y, Shi Y, et al
    Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis.
    J Immunother. 2023;46:43-55.
    Abstract     Related articles   

  289. HUANG YP, Huang EY, Chung HJ, Tai MC, et al
    Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?
    J Endourol. 2023;37:139-146.
    Abstract     Related articles   

  290. JIA K, Wang Y, Yang B, Wang H, et al
    Revisit the rare clinical cases of upper urinary tract metastases from gastrointestinal tumors.
    Asian J Surg. 2023;46:1103-1104.
    Abstract     Related articles   

  291. CHAO CW, Chung SD, Au CF
    Primary bladder amyloidosis mimicking bladder malignancy: A case report.
    Asian J Surg. 2023;46:1033-1035.
    Abstract     Related articles   

  292. CHENG TY, Tang TY, Hsu JM, Lin TF, et al
    Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: A case report and literature review.
    Asian J Surg. 2023;46:969-970.
    Abstract     Related articles   

  293. TAN Z, Wang H, Wang J
    A commentary on 'systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer' (Int J S
    Int J Surg. 2023;109:208-210.
    Abstract     Related articles   

  294. YANG Y, Wang C, Li Z, Lu Q, et al
    Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective.
    Front Oncol. 2023;13:1042552.
    Abstract     Related articles   

  295. SEVIM NALKIRAN H, Akcora Yildiz D, Saydam F, Guzel AI, et al
    Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer.
    Saudi J Biol Sci. 2023;30:103564.
    Abstract     Related articles   

  296. TAPPERO S, Sorce G, Panunzio A, Hohenhorst L, et al
    Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
    Cent European J Urol. 2022;75:352-356.
    Abstract     Related articles   

  297. KOLL FJ, Banek S, Kluth L, Kollermann J, et al
    Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
    J Transl Med. 2023;21:124.
    Abstract     Related articles   

  298. WANG L, Wu S, He H, Ai K, et al
    CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1/P38 axis.
    Lab Invest. 2022;102:1323-1334.
    Abstract     Related articles   

  299. AL-ZUBI MT, Demour SA, Al-Rawashdah SF, Carbone A, et al
    Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
    Future Sci OA. 2023;8:FSO823.
    Abstract     Related articles   

  300. MALEK-ESFANDIARI Z, Rezvani-Noghani A, Sohrabi T, Mokaberi P, et al
    Molecular Dynamics and Multi-Spectroscopic of the Interaction Behavior between Bladder Cancer Cells and Calf Thymus DNA with Rebeccamycin: Apoptosis through the Down Regulation of PI3K/AKT Signaling Pathway.
    J Fluoresc. 2023 Feb 14. doi: 10.1007/s10895-023-03169.
    Abstract     Related articles   

  301. LIU P, Xu L, Chen G, Shi B, et al
    Nomograms for predicting survival in patients with micropapillary bladder cancer: a real-world analysis based on the surveillance, epidemiology, and end results database and external validation in a tertiary center.
    BMC Urol. 2023;23:16.
    Abstract     Related articles   

  302. ZHANG Z, Mou Z, Xu C, Wu S, et al
    Correction: Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Cell Death Dis. 2023;14:113.
    Abstract     Related articles   

  303. VON DEIMLING M, Schuettfort VM, D'Andrea D, Pradere B, et al
    Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Jan 26:S1558-7673(23)00031.
    Abstract     Related articles   

  304. ZHONG SJ, Gao JJ, Tang P, Liu YP, et al
    [The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
    Zhonghua Zhong Liu Za Zhi. 2023;45:175-181.
    Abstract     Related articles   

  305. VAN ZUTPHEN M, Hof JP, Aben KK, Kampman E, et al
    Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
    Am J Clin Nutr. 2023 Feb 11:S0002-9165(23)04155.
    Abstract     Related articles   

  306. ZHU J, Huang X, Liu L, Wang N, et al
    Can the Vesical Imaging Reporting and Data System (VI-RADS) score be applied in conventional ultrasound and contrast-enhanced ultrasound to differentiate muscle-invasive bladder cancer?
    Med Ultrason. 2023 Feb 7. doi: 10.11152/mu-3841.
    Abstract     Related articles   

  307. WONG JL, Smith P, Angulo-Lozano J, Ranti D, et al
    IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer.
    bioRxiv. 2023 Feb 1:2023.01.30.526266. doi: 10.1101/2023.01.30.526266.
    Abstract     Related articles   

  308. LI S, Jiang M, Yang L, Zheng F, et al
    Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer.
    Front Genet. 2023;14:1062060.
    Abstract     Related articles   

  309. DE SOUZA AL, Mega AE, Douglass J, Olszewski AJ, et al
    Clinical features of patients with MTAP-deleted bladder cancer.
    Am J Cancer Res. 2023;13:326-339.
    Abstract     Related articles   

  310. LOPES S, Pabst L, Dory A, Klotz M, et al
    Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
    Front Immunol. 2023;14:1070076.
    Abstract     Related articles   

  311. SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
    Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
    Lab Invest. 2022;102:1143-1149.
    Abstract     Related articles   

  312. LI F, Zheng Z, Chen W, Li D, et al
    Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
    Drug Resist Updat. 2023;68:100938.
    Abstract     Related articles   

  313. AMINOLTEJARI K, Hird AE, Klaassen Z, Satkunasivam R, et al
    Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses.
    Ann Surg Oncol. 2023 Feb 11. doi: 10.1245/s10434-022-12692.
    Abstract     Related articles   

  314. TSILI AC, Varkarakis I, Pasoglou V, Anagnostou N, et al
    CT of the urinary tract revisited.
    Eur J Radiol. 2023;160:110717.
    Abstract     Related articles   

  315. ZHENG Q, Jiang Z, Ni X, Yang S, et al
    Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2023;24:2746.
    Abstract     Related articles   

  316. GIANNIOU DD, Sklirou AD, Papadimitriou MA, Pilala KM, et al
    Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
    Int J Mol Sci. 2023;24:2609.
    Abstract     Related articles   

    In Vivo Optical Imaging of Bladder Cancer Tissues in an MB49 Bladder Cancer Orthotopic Mouse Model Using the Intravesical or Intravenous Administration of Near-Infrared Fluorescence Probe.
    Int J Mol Sci. 2023;24:2349.
    Abstract     Related articles   

  318. HAGHAYEGH S, Liu Y, Zhang Y, Strohmaier S, et al
    Rotating Night Shift Work and Bladder Cancer Risk in Women: Results of Two Prospective Cohort Studies.
    Int J Environ Res Public Health. 2023;20:2202.
    Abstract     Related articles   

  319. KOWALD S, Huge Y, Tandiono D, Ali Z, et al
    Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer.
    Cells. 2023;12:508.
    Abstract     Related articles   

  320. AFONSO J, Goncalves C, Costa M, Ferreira D, et al
    Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.
    Cancers (Basel). 2023;15:982.
    Abstract     Related articles   

  321. ZHANG Y, Wang W, Zhou H, Cui Y, et al
    Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway.
    Cancers (Basel). 2023;15:809.
    Abstract     Related articles   

  322. PAPAVASILIOU E, Sills VA, Calanzani N, Harrison H, et al
    Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2023;15:709.
    Abstract     Related articles   

  323. KAMECKI H, Debowska M, Poleszczuk J, Demkow T, et al
    Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival.
    Cancers (Basel). 2023;15:668.
    Abstract     Related articles   

  324. LIU J, Zhou Z, Jiang Y, Lin Y, et al
    EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer.
    Cancers (Basel). 2023;15:621.
    Abstract     Related articles   

  325. LEONARDO C, Flammia RS, Lucciola S, Proietti F, et al
    Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.
    Cancers (Basel). 2023;15:580.
    Abstract     Related articles   

  326. ESTEBAN-VILLARRUBIA J, Torres-Jimenez J, Bueno-Bravo C, Garcia-Mondaray R, et al
    Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:566.
    Abstract     Related articles   

  327. PAPPOT H, Ullen A
    Optimal Systemic Treatment of Advanced Bladder Cancer Calls for a Multidisciplinary Approach.
    Cancers (Basel). 2023;15:559.
    Abstract     Related articles   

  328. GANJI M, Bakhshi S, Shoari A, Ahangari Cohan R, et al
    Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.
    J Transl Med. 2023;21:111.
    Abstract     Related articles   

  329. SUN Z, Jing C, Zhan H, Guo X, et al
    Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine.
    Front Immunol. 2023;14:1097472.
    Abstract     Related articles   

  330. KIMURA Y, Fujimori M, Rajagopalan NR, Poudel K, et al
    Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-beta1.
    Front Immunol. 2023;14:1070196.
    Abstract     Related articles   

  331. HATAKEYAMA S, Ohyama C
    [â…¡. Update on Guideline for Management of Metastatic Urothelial Carcinoma].
    Gan To Kagaku Ryoho. 2023;50:45-49.
    Abstract     Related articles   

  332. MOLLER K, Knoll M, Bady E, Schmerder MJ, et al
    PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples.
    Cancer Biomark. 2023;36:177-191.
    Abstract     Related articles   

  333. SHIGETA K, Hasegawa M, Hishiki T, Naito Y, et al
    IDH2 stabilizes HIF-1alpha-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
    EMBO J. 2023;42:e110620.
    Abstract     Related articles   

  334. ANBARASAN T, Nissar S, Turbitt J, Walls K, et al
    Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
    Scott Med J. 2023;68:4-13.
    Abstract     Related articles   

  335. YIRGA L, Hadaschik B, Burger M, Pullen L, et al
    [Photodynamic TUR-B: it looks better than it is : Comment on the randomized study].
    Urologie. 2023;62:181-183.
    Abstract     Related articles   

  336. RAHMAN SN, Lokeshwar SD, Syed JS, Javier-Desloges JF, et al
    Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
    Urol Oncol. 2023;41:107.
    Abstract     Related articles   

  337. BIANCHI A, von Deimling M, Pallauf M, Yanagisawa T, et al
    Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond.
    Expert Opin Pharmacother. 2023;24:177-195.
    Abstract     Related articles   

  338. ALSYOUF M, Ladi-Seyedian SS, Konety B, Pohar K, et al
    Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
    Urol Oncol. 2023;41:109.
    Abstract     Related articles   

  339. SMELSER WW, Tallman JE, Gupta VK, Al Hussein Al Awamlh B, et al
    Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy.
    Urol Oncol. 2023;41:108.
    Abstract     Related articles   

  340. HUYNH MA, Tang C, Siva S, Berlin A, et al
    Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Eur Urol Oncol. 2023;6:28-38.
    Abstract     Related articles   

  341. MOMO OM, Otake S, Minamikawa S, Ohkusu K, et al
    Painless subcutaneous abscess caused by bacillus Calmette-Guerin osteomyelitis.
    Pediatr Int. 2023;65:e15381.
    Abstract     Related articles   

  342. YANG Z, Bi Y, Xu W, Guo R, et al
    Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.
    Chem Biol Drug Des. 2023;101:581-592.
    Abstract     Related articles   

  343. JARDIM DLF, Millis SZ, Ross JS, Lippman S, et al
    Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
    Oncologist. 2023;28:e82-e91.
    Abstract     Related articles   

  344. TUO Z, Wang J, Zhang Y, Bi L, et al
    Learning Curve of a Novel Three-Port Laparoscopic Radical Cystectomy with Urinary Diversion: A Single-Center Retrospective Analysis.
    J Laparoendosc Adv Surg Tech A. 2023;33:188-193.
    Abstract     Related articles   

  345. SUN H, Wang X
    High-dimensional feature selection in competing risks modeling: A stable approach using a split-and-merge ensemble algorithm.
    Biom J. 2023;65:e2100164.
    Abstract     Related articles   

  346. ARITA Y, Yoshida S, Shigeta K, Kwee TC, et al
    Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Eur Urol Oncol. 2023;6:99-102.
    Abstract     Related articles   

  347. ACOSTA AM, Demicco EG, Dal Cin P, Hirsch MS, et al
    Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Mod Pathol. 2021;34:469-477.
    Abstract     Related articles   

  348. CHANG CH, Lin BJ, Chen CH, Nguyen NL, et al
    Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade.
    Mar Drugs. 2023;21:73.
    Abstract     Related articles   

  349. WU Z, Zeng J, Wu M, Liang Q, et al
    Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer.
    Medicine (Baltimore). 2023;102:e33075.
    Abstract     Related articles   

  350. GAISA NT, Hartmann A, Knuchel-Clarke R
    [New WHO classification 2022: urinary bladder cancer].
    Pathologie (Heidelb). 2023 Feb 24. doi: 10.1007/s00292-023-01183.
    Abstract     Related articles   

  351. SEISEN T, Labban M, Lipsitz SR, Preston MA, et al
    Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States.
    Curr Oncol. 2023;30:1986-1998.
    Abstract     Related articles   

    Adjuvant intravesical chemohyperthermia or conventional chemotherapy in an era of bacillus Calmette-Guerin shortage for non-muscle invasive bladder cancer: The HIVEC-II trial.
    Indian J Urol. 2023;39:75-76.
    Abstract     Related articles   

  353. GRABENBAUER F, Flentje M
    [Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study].
    Strahlenther Onkol. 2023 Feb 23. doi: 10.1007/s00066-023-02052.
    Abstract     Related articles   

  354. ZHANG L, Liu B, Su J
    CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
    Medicine (Baltimore). 2023;102:e32825.
    Abstract     Related articles   

  355. WU P, Wu K, Li Z, Liu H, et al
    Multimodal investigation of bladder cancer data based on computed tomography, whole slide imaging, and transcriptomics.
    Quant Imaging Med Surg. 2023;13:1023-1035.
    Abstract     Related articles   

  356. MATIC M, Dmitrovic B, Matic S, Kurbel S, et al
    Acta Clin Croat. 2022;61:239-247.
    Abstract     Related articles   

  357. AWADA H, Ali AH, Zeineddine MA, Nassereldine H, et al
    The status of bladder cancer research worldwide, a bibliometric review and recommendations.
    Arab J Urol. 2022;21:1-9.
    Abstract     Related articles   

  358. BENITEZ R, Yu K, Sirota M, Malats N, et al
    Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
    Front Immunol. 2023;14:986598.
    Abstract     Related articles   

  359. LIU S, Yao Y, Wang ZK, Sun LJ, et al
    Prognostic value of the sarcomatoid component in bladder cancer: A propensity score matching study.
    Oncol Lett. 2023;25:103.
    Abstract     Related articles   

  360. SHAH SD, Gillard BM, Wrobel MM, Karasik E, et al
    Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
    Front Oncol. 2023;13:1120329.
    Abstract     Related articles   

  361. GOTSCHALL JW, Major CK, Jacobs LA, Blauch A, et al
    Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study.
    BJUI Compass. 2022;4:164-166.
    Abstract     Related articles   

  362. MIAN A, Wei J, Shi Z, Rifkin AS, et al
    Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
    BJUI Compass. 2022;4:156-163.
    Abstract     Related articles   

  363. ZHOU TL, Chen HX, Wang YZ, Wen SJ, et al
    Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis.
    Front Immunol. 2023;14:1083598.
    Abstract     Related articles   

  364. KOSITZA J, Nguyen J, Hong T, Mantwill K, et al
    Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer.
    Urol Oncol. 2023 Feb 20:S1078-1439(23)00010.
    Abstract     Related articles   

  365. FU S, Luan T, Jiang C, Huang Y, et al
    Corrigendum to "miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2" [Gene 701 (2019) 23-31].
    Gene. 2023;862:147266.
    Abstract     Related articles   

  366. PIGNOT G, Baboudjian M, Lebacle C, Chamouni A, et al
    Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
    World J Urol. 2023 Feb 22. doi: 10.1007/s00345-023-04332.
    Abstract     Related articles   

  367. SONG Y, Qin C, Zhang C, Peng Y, et al
    GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females.
    J Cancer Res Clin Oncol. 2023 Feb 19. doi: 10.1007/s00432-023-04640.
    Abstract     Related articles   

  368. ALSHEHRI E, Al-Dogmi AM, Al-Hazani TMI, Alwaili MA, et al
    Patterns of mutations in nine cancer-related genes and PAF development among smoking male patients diagnosed with bladder cancer.
    Tumour Biol. 2023;45:1-14.
    Abstract     Related articles   

  369. WANG N, Chen RX, Deng MH, Wei WS, et al
    m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization.
    Cell Death Dis. 2023;14:139.
    Abstract     Related articles   

  370. MARQUES M, Corral S, Sanchez-Diaz M, Del Pozo N, et al
    Tumor and stromal cell targeting with Nintedanib and Alpelisib overcomes intrinsic bladder cancer resistance.
    Mol Cancer Ther. 2023 Feb 20:MCT-21-0667. doi: 10.1158/1535-7163.MCT-21-0667.
    Abstract     Related articles   

  371. GUNERI-SOZERI PY, Ozden-Yilmaz G, Kisim A, Cakiroglu E, et al
    FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer.
    Commun Biol. 2023;6:199.
    Abstract     Related articles   

  372. INMAN BA, Hahn NM, Stratton K, Kopp R, et al
    A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Feb 15:S2588-9311(23)00032.
    Abstract     Related articles   

  373. CHENG TH, Lu ZH, Hsu CW
    Gross hematuria as the presentation of ureteral paraganglioma: a case report and literature review.
    BMC Urol. 2023;23:21.
    Abstract     Related articles   

  374. LI S, Zhang J, Tian Y, Zhu Y, et al
    De novo upper tract urothelial carcinoma after renal transplantation: a single-center experience in China.
    BMC Urol. 2023;23:23.
    Abstract     Related articles   

  375. LI X, Xiong W, Wang Y, Li Y, et al
    p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
    Lab Invest. 2023;103:100058.
    Abstract     Related articles   

  376. YOHANA C, Bakuza JS, Kinung'hi SM, Nyundo BA, et al
    The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period.
    Infect Agent Cancer. 2023;18:10.
    Abstract     Related articles   

  377. SEOK J, Kwak HJ, Kwak Y, Lee M, et al
    Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.
    J Transl Med. 2023;21:129.
    Abstract     Related articles   

  378. SARKIS J, Diamand R, Aoun F, Assenmacher G, et al
    Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.
    Minerva Urol Nephrol. 2023;75:50-58.
    Abstract     Related articles   

  379. JHAN JH, Ke HL, Liang PI, Hsu WC, et al
    High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas.
    Appl Immunohistochem Mol Morphol. 2023;31:94-100.
    Abstract     Related articles   

  380. KORGVEE A, Veskimae E, Huhtala H, Koskinen H, et al
    Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: a randomized clinical trial.
    Acta Anaesthesiol Scand. 2022 Dec 22. doi: 10.1111/aas.14188.
    Abstract     Related articles   

  381. GUFFROY M, Trela B, Kambara T, Stawski L, et al
    Selective inhibition of integrin alphavbeta6 leads to rapid induction of urinary bladder tumors in cynomolgus macaques.
    Toxicol Sci. 2023;191:400-413.
    Abstract     Related articles   

  382. CHAU M, Thia I, Viswambaram P, Hawks C, et al
    Lymph node assessment technique matters in radical cystectomy for bladder cancer.
    ANZ J Surg. 2023 Mar 3. doi: 10.1111/ans.18292.
    Abstract     Related articles   

  383. IMAMVERDIYEV S, Qasimov E, Naghiyev R
    Georgian Med News. 2023;:98-102.
    Abstract     Related articles   

  384. XU H, Liu Z, Weng S, Ren Y, et al
    Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer.
    Clin Transl Med. 2023;13:e1145.
    Abstract     Related articles   

  385. IKEDA M, Uemura K, Araki Y, Iribe Y, et al
    [A Case of Long-Term Survival Following Multidisciplinary Therapy for Small Intestinal Metastasis of Bladder Cancer].
    Hinyokika Kiyo. 2023;69:55-58.
    Abstract     Related articles   

  386. DE HAAR-HOLLEMAN A, van Hoogstraten LMC, C C M Hulshof M, Tascilar M, et al
    Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: a nationwide cohort study.
    Radiother Oncol. 2023 Feb 28:109584. doi: 10.1016/j.radonc.2023.109584.
    Abstract     Related articles   

  387. TACAR SY, Yilmaz M, Baytekin HF, Tural D, et al
    Evaluation of predictive factors in patients with bladder cancer undergoing atezolizumab treatment: Case reports.
    Indian J Cancer. 2022;59:556-559.
    Abstract     Related articles   

  388. Retraction: CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
    Biosci Rep. 2023;43:BSR-2019-1961.
    Abstract     Related articles   

  389. AN HW, Hou DY, Yang J, Wang ZQ, et al
    A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence.
    Sci Adv. 2023;9:eabq8225.
    Abstract     Related articles   

  390. YU Z, Lu C, Lai Y
    A serum miRNAs signature for early diagnosis of bladder cancer.
    Ann Med. 2023;55:736-745.
    Abstract     Related articles   

  391. MAZZASCHI G, Giudice GC, Coriano M, Campobasso D, et al
    Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
    Technol Cancer Res Treat. 2023;22:15330338231159753.
    Abstract     Related articles   

  392. LI X, Fu C, Li G, He H, et al
    RNA-seq reveals novel mechanistic targets of Livin in bladder cancer.
    BMC Urol. 2023;23:26.
    Abstract     Related articles   

  393. LI SH, Zhai GQ, He RQ, Chen G, et al
    Down-regulation and clinical significance of Sorbin and SH3 domain-containing protein 1 in bladder cancer tissues.
    IET Syst Biol. 2023 Feb 28. doi: 10.1049/syb2.12060.
    Abstract     Related articles   

  394. WANG XF, Liu DL, Geng L
    The PSCA rs2294008 (C/T) Polymorphism Increases the Risk of Gastric and Bladder Cancer: A Meta-Analysis.
    Genet Test Mol Biomarkers. 2023;27:44-55.
    Abstract     Related articles   

  395. MCELREE IM, Steinberg RL, Mott SL, O'Donnell MA, et al
    Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer.
    JAMA Netw Open. 2023;6:e230849.
    Abstract     Related articles   

  396. YOUSSIEF MOHAMMED AA, Gamal DA, Abd Elzaher AR, Hasaballah A, et al
    Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in Muscle Invasive TCC Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2023;24:517-524.
    Abstract     Related articles   

  397. FENG R, Li Z, Ge G, Wang C, et al
    Cancer-associated fibroblast-derived extracellular vesicles mediate immune escape of bladder cancer via PD-L1/PD-1 expression.
    Endocr Metab Immune Disord Drug Targets. 2023.
    Abstract     Related articles   

  398. WANG W, Chen L, Yang J, Hu D, et al
    Apatinib Inhibits Bladder Cancer through Suppression of The VEGFR2-PI3K-AKT Signaling Pathway as revealed by Network Pharmacology and In Vitro Experimental Verification.
    Comb Chem High Throughput Screen. 2023.
    Abstract     Related articles   

  399. KOKURA K, Watanabe J, Takuma T, Uketa S, et al
    A case of Avelumab response to multiple bone and lymph node metastases of plasmacytoid variant bladder cancer.
    Urol Case Rep. 2023;47:102358.
    Abstract     Related articles   

  400. LIU Y, Zhao YC, Lu Y, Goodarz D, et al
    The role of smoking in explaining racial/ethnic disparities in bladder cancer incidence in the United States.
    Urol Oncol. 2023 Feb 25:S1078-1439(23)00051.
    Abstract     Related articles   

  401. KERIOUI M, Bertrand J, Desmee S, Le Tourneau C, et al
    Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?
    JCO Precis Oncol. 2023;7:e2200368.
    Abstract     Related articles   

  402. DUQUESNE I, Benamran D, Masson-Lecomte A, De La Taille A, et al
    Intraoperative complication of radical cystectomy for muscle-invasive bladder cancer: does the surgical approach matter? A retrospective multicenter study using the EAUiaiC classification.
    World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04340.
    Abstract     Related articles   

  403. FRANCO N, Godono A, Clari M, Ciocan C, et al
    Occupational asbestos exposure and urinary bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04327.
    Abstract     Related articles   

  404. GUPTA P, Sarangi SS, Singh M, Pandey H, et al
    To determine correlation between VIRADS scoring and pathological staging in bladder cancer: A prospective study and review of literature.
    Urologia. 2023 Feb 27:3915603231151738. doi: 10.1177/03915603231151738.
    Abstract     Related articles   

  405. WOLF P
    Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer.
    Front Oncol. 2023;13:1124600.
    Abstract     Related articles   

  406. MAJA SG, Slavica KK, Suad A, Rubens J, et al
    Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report.
    Pan Afr Med J. 2022;42:221.
    Abstract     Related articles   

  407. WANG Z, Wang J, Zhang W, Wang D, et al
    Case report: Urothelial carcinoma of the renal pelvis with trophoblastic differentiation: A rare case report and review of literature.
    Pathol Oncol Res. 2023;29:1610856.
    Abstract     Related articles   

    BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
    Actas Urol Esp (Engl Ed). 2023 Feb 24:S2173-5786(23)00018.
    Abstract     Related articles   

  409. HE HL, Lai HY, Chan TC, Hsing CH, et al
    Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder.
    World J Surg Oncol. 2023;21:62.
    Abstract     Related articles   

  410. LIU Z, Song L, Xie J, Wu XR, et al
    Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.
    Molecules. 2023;28:1666.
    Abstract     Related articles   

  411. LEMINSKI A, Michalski W, Masojc B, Kaczmarek K, et al
    Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review.
    J Clin Med. 2023;12:1560.
    Abstract     Related articles   

  412. WEN P, Wen J, Huang X, Wang F, et al
    Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program.
    J Clin Med. 2023;12:1314.
    Abstract     Related articles   

  413. BOSCHI F, Malatesta M
    Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.
    Int J Mol Sci. 2023;24:3812.
    Abstract     Related articles   

  414. SANGUEDOLCE F, Zanelli M, Palicelli A, Bisagni A, et al
    HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role.
    Int J Mol Sci. 2023;24:3720.
    Abstract     Related articles   

  415. YANG CC, Chuang FC, Chang CL, Huang CR, et al
    Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrP(C)-Regulated Cell Stress and Cell Proliferation Signaling.
    Int J Mol Sci. 2023;24:3353.
    Abstract     Related articles   

  416. LIN PT, Hung WK, Chang YH, Hsieh ML, et al
    Replacement Instead of Discontinuation of Bacillus Calmette-Guerin Instillation in Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:1345.
    Abstract     Related articles   

  417. LEE MC, Wang SY, Pan CT, Chien MY, et al
    Development of Deep Learning with RDA U-Net Network for Bladder Cancer Segmentation.
    Cancers (Basel). 2023;15:1343.
    Abstract     Related articles   

  418. LEE HW, Kwon WA, Nguyen NT, Phan DTT, et al
    Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations.
    Cancers (Basel). 2023;15:1323.
    Abstract     Related articles   

  419. ABOUDARAM A, Chaltiel L, Pouessel D, Graff-Cailleaud P, et al
    Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
    Cancers (Basel). 2023;15:1161.
    Abstract     Related articles   

  420. GAO Y, Cao H, Huang D, Zheng L, et al
    RNA-Binding Proteins in Bladder Cancer.
    Cancers (Basel). 2023;15:1150.
    Abstract     Related articles   

  421. WANG H, Feng Y, Zheng X, Xu X, et al
    The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer.
    Cancers (Basel). 2023;15:1007.
    Abstract     Related articles   

  422. KOLL FJ, Metzger E, Hamann J, Ramos-Triguero A, et al
    Overexpression of KMT9alpha Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer.
    Cells. 2023;12:589.
    Abstract     Related articles   

  423. SHI Y, Mathis BJ, He Y, Yang X, et al
    The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer.
    Biomedicines. 2023;11:539.
    Abstract     Related articles   

  424. JAIN M, Tivtikyan A, Kamalov D, Avdonin S, et al
    Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies.
    Biomedicines. 2023;11:495.
    Abstract     Related articles   

  425. GALINIAK S, Molon M, Biesiadecki M, Mokrzynska A, et al
    Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer.
    Antioxidants (Basel). 2023;12:277.
    Abstract     Related articles   

  426. ZONA A, Fazzo L, Benedetti M, Bruno C, et al
    [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Epidemiol Prev. 2023;47.
    Abstract     Related articles   

  427. CINAR NB, Yilmaz H, Avci IE, Cakmak K, et al
    Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria.
    World J Surg Oncol. 2023;21:58.
    Abstract     Related articles   

  428. MARTINEZ-VIDAL L, Chighizola M, Berardi M, Alchera E, et al
    Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence.
    Commun Biol. 2023;6:217.
    Abstract     Related articles   

  429. JOSHI M, Tuanquin L, Zhu J, Walter V, et al
    Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
    J Immunother Cancer. 2023;11:e006551.
    Abstract     Related articles   

  430. TANG Q, Zuo W, Wan C, Xiong S, et al
    Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
    Front Immunol. 2023;13:1097730.
    Abstract     Related articles   

  431. ALRADHI M, Wen S, Safi M, Al-Danakh A, et al
    Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
    Cancer Med. 2023;12:3931-3951.
    Abstract     Related articles   

  432. RASPOLLINI MR, Comperat EM, Lopez-Beltran A, Montironi R, et al
    News in the classification of WHO 2022 bladder tumors.
    Pathologica. 2022;115:32-40.
    Abstract     Related articles   

  433. BOULEFTOUR W, Sargos P, Magne N
    Nectin-4: a Tumor Cell Target and Status of Inhibitor Development.
    Curr Oncol Rep. 2023;25:181-188.
    Abstract     Related articles   

  434. HU X, Wang K, Sun M, Li C, et al
    Quantitative MRI in distinguishing bladder paraganglioma from bladder leiomyoma.
    Abdom Radiol (NY). 2023;48:1051-1061.
    Abstract     Related articles   

  435. PEREZ-MONTIEL D, Olivares-Mundo A, Jimenez-Rios MA, Morera CS, et al
    Influence of luminal and basal subtype in prognosis of high-grade non muscle invasive urothelial carcinoma.
    Ann Diagn Pathol. 2023;63:152081.
    Abstract     Related articles   

  436. BABAN F, Auen T, Eschbacher KL, Swanson AA, et al
    Invasive urothelial carcinoma with squamous differentiation and associated high-risk human papilloma virus infection: Clinical, cytologic, and histologic features of a rare entity.
    Ann Diagn Pathol. 2023;63:152103.
    Abstract     Related articles   

  437. FUJIKI T, Sakai Y, Ikawa Y, Takenaka M, et al
    Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib.
    Pediatr Blood Cancer. 2023;70:e30172.
    Abstract     Related articles   

  438. PETEINARIS A, Kallidonis P, Tsaturyan A, Pagonis K, et al
    The feasibility of robot-assisted radical cystectomy: an experimental study.
    World J Urol. 2023;41:477-482.
    Abstract     Related articles   

  439. SYED M, Mushtaq S, Loya A, Hassan U, et al
    Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
    Ann Diagn Pathol. 2023;63:152079.
    Abstract     Related articles   

  440. GAO S, Zhou XQ, Wu Q, Chen XD, et al
    Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
    Tohoku J Exp Med. 2023;259:209-219.
    Abstract     Related articles   

  441. HEKMAN MCH, Wijn SRW, Lotan Y, Govers TM, et al
    Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis.
    World J Urol. 2023;41:471-476.
    Abstract     Related articles   

  442. BALAR AV, Castellano DE, Grivas P, Vaughn DJ, et al
    Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
    Ann Oncol. 2023;34:289-299.
    Abstract     Related articles   

  443. BREHMER M
    Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on "Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 20
    Scand J Urol. 2023;57.
    Abstract     Related articles   

  444. BALAWENDER K, Wawrzyniak A, Walocha J, Mazur M, et al
    Leiomyoma: a case of a rare benign mesenchymal neoplasm of the urinary bladder.
    Pol Arch Intern Med. 2023;133:16381.
    Abstract     Related articles   

  445. KARTTUNEN E, Hervonen P, Hosseini Aliabad A, Oldenburg J, et al
    Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.
    Scand J Urol. 2023;57.
    Abstract     Related articles   

  446. BOROWCZAK J, Szczerbowski K, Maniewski M, Zdrenka M, et al
    The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma.
    Clin Transl Oncol. 2023;25:830-840.
    Abstract     Related articles   

  447. ALTIERI MA, Sarmiento-Machado LM, Romualdo GR, de Moura NA, et al
    Dietary Capsaicin Reduces Chemically Induced Rat Urinary Bladder Carcinogenesis.
    Plant Foods Hum Nutr. 2023;78:93-99.
    Abstract     Related articles   

  448. MOEEN AM, Behnsawy HM, Faragallah MA, Gadelkareem RA, et al
    Functional evaluation of a spiral neobladder with an angled chimney; A prospective randomized comparative study.
    Eur J Surg Oncol. 2023;49:491-496.
    Abstract     Related articles   

  449. LIMONNIK V, Samiei A, Abel S, Wegner RE, et al
    Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
    Cancer Med. 2023;12:2752-2760.
    Abstract     Related articles   

  450. MATSUBARA N, Yonese J, Kojima T, Azuma H, et al
    Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma.
    Cancer Med. 2023;12:2761-2771.
    Abstract     Related articles   

  451. SONPAVDE GP, Maughan BL, McGregor BA, Wei XX, et al
    Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
    Cancer Immunol Immunother. 2023;72:775-782.
    Abstract     Related articles   

  452. HUANG J, Huang D, Ruan X, Huang J, et al
    Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank.
    Cancer Med. 2023;12:3468-3476.
    Abstract     Related articles   

  453. WU Y, Zhu W, Wang J, Liu L, et al
    Using machine learning for mortality prediction and risk stratification in atezolizumab-treated cancer patients: Integrative analysis of eight clinical trials.
    Cancer Med. 2023;12:3744-3757.
    Abstract     Related articles   

  454. ITO K, Kita Y, Yokomizo A, Miki J, et al
    Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study.
    Cancer Med. 2023;12:2325-2332.
    Abstract     Related articles   

  455. BORET S, Lambert E, Charles VP, Philippe T, et al
    Vulvar pagetoid urothelial intraepithelial neoplasia: a case report.
    Acta Chir Belg. 2023;123:174-177.
    Abstract     Related articles   

  456. LENTZSCH AM, Siggel R, Schnorr C, Holtick U, et al
    Retin Cases Brief Rep. 2023;17:105-110.
    Abstract     Related articles   

  457. COCKRELL DC, Rose TL
    Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions.
    Curr Oncol Rep. 2023 Mar 10. doi: 10.1007/s11912-023-01390.
    Abstract     Related articles   

  458. YANAGISAWA T, Matsukawa A, Iwatani K, Sato S, et al
    En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2023 Mar 10. doi: 10.1245/s10434-023-13227.
    Abstract     Related articles   

  459. GRABE-HEYNE K, Henne C, Odeyemi I, Pohlmann J, et al
    Evaluating the cost-utility of intravesical bacillus calmette-guerin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK.
    J Med Econ. 2023 Mar 10:1-19. doi: 10.1080/13696998.2023.2189860.
    Abstract     Related articles   

  460. HU X, Sun C, Ren X, Ge S, et al
    Contrast-enhanced Ultrasound Combined With Elastography for the Evaluation of Muscle-invasive Bladder Cancer in Rats.
    J Ultrasound Med. 2023 Mar 10. doi: 10.1002/jum.16216.
    Abstract     Related articles   

  461. YAMAMOTO Y, Kawashima A, Morishima T, Uemura T, et al
    Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer.
    Adv Radiat Oncol. 2022;8:101157.
    Abstract     Related articles   

  462. WANG H, Li J, Zi X, Yuan X, et al
    Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity.
    Front Oncol. 2023;13:1116305.
    Abstract     Related articles   

  463. WU S, Hong G, Xu A, Zeng H, et al
    Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
    Lancet Oncol. 2023 Mar 6:S1470-2045(23)00061.
    Abstract     Related articles   

  464. MANDRIK O, Hahn AI, Catto JWF, Zauber AG, et al
    Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review.
    Pharmacoeconomics. 2023 Mar 8. doi: 10.1007/s40273-023-01256.
    Abstract     Related articles   

  465. ZUKOV RA, Savchenko AA, Slepov EV, Semenov EV, et al
    Phenotype of Urine Sediment Cells in Patients with Bladder Cancer.
    Bull Exp Biol Med. 2023 Mar 9. doi: 10.1007/s10517-023-05732.
    Abstract     Related articles   

  466. CARAMELO B, Zagorac S, Corral S, Marques M, et al
    Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Eur Urol Oncol. 2023 Mar 6:S2588-9311(23)00043-3. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  467. YAMADA Y, Kume H
    [Frailty and surgical tolerability in elderly patients undergoing robot-assisted radical cystectomy (RARC)].
    Nihon Ronen Igakkai Zasshi. 2023;60:38-42.
    Abstract     Related articles   

  468. JIN D, Qian L, Xia J, Zhang R, et al
    In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer.
    Med Oncol. 2023;40:113.
    Abstract     Related articles   

  469. FAN X, Yu H, Ni X, Chen G, et al
    Systematic radiomics analysis based on multiparameter MRI to preoperatively predict the expression of Ki67 and histological grade in patients with bladder cancer.
    Br J Radiol. 2023 Mar 8:20221086. doi: 10.1259/bjr.20221086.
    Abstract     Related articles   

  470. PASSALACQUA MI, Squeri A, Sciume C, Ieni A, et al
    Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.
    Acta Biomed. 2023;94.
    Abstract     Related articles   

  471. SHU TD, Schumacher FR, Conroy B, Ponsky L, et al
    Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database.
    Cancer Causes Control. 2023 Mar 8. doi: 10.1007/s10552-023-01679.
    Abstract     Related articles   

  472. TAPPERO S, Barletta F, Piccinelli ML, Cano Garcia C, et al
    Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
    Urol Oncol. 2023 Mar 5:S1078-1439(23)00015-7. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  473. AKDEMIR E, Sweegers MG, Vrieling A, Rundqvist H, et al
    EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.
    BMJ Open. 2023;13:e071304.
    Abstract     Related articles   

  474. JEONG SH, Ku JH
    Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Investig Clin Urol. 2023;64:103-106.
    Abstract     Related articles   

  475. NAGAHISA C, Iizuka J, Kobari Y, Minoda R, et al
    Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases.
    In Vivo. 2023;37:912-915.
    Abstract     Related articles   

  476. CHEN L, Dong W, Zhou M, Yang C, et al
    PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression.
    Cell Biosci. 2023;13:45.
    Abstract     Related articles   

  477. CIARAMELLA A, Di Nardo E, Terracciano D, Conte L, et al
    A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology.
    BMC Bioinformatics. 2023;23.
    Abstract     Related articles   

  478. LEE YS, Ha MS, Tae JH, Chang IH, et al
    Gemcitabine-cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study.
    Sci Rep. 2023;13:3682.
    Abstract     Related articles   

  479. SCHMOKEL SS, Nordentoft I, Lindskrog SV, Lamy P, et al
    Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies.
    Nucleus. 2023;14:2186686.
    Abstract     Related articles   

  480. JIN D, Qian L, Xia J, Zhang R, et al
    In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy.
    Cell Oncol (Dordr). 2023 Mar 6. doi: 10.1007/s13402-023-00785.
    Abstract     Related articles   

  481. In brief: Adstiladrin - a gene therapy for bladder cancer.
    Med Lett Drugs Ther. 2023;65:e40-e41.
    Abstract     Related articles   

  482. YOSHIOKA F, Kato T, Shima Y, Hatano K, et al
    Drug-induced interstitial pneumonia after intravesical Bacillus Calmette-Guerin administration for bladder cancer with scleroderma.
    IJU Case Rep. 2023;6:133-136.
    Abstract     Related articles   

  483. COLLACOTT H, Krucien N, Heidenreich S, Catto JWF, et al
    Patient Preferences for Treatment of Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: A Cross-country Choice Experiment.
    Eur Urol Open Sci. 2023;49:92-99.
    Abstract     Related articles   

  484. WU Y, Xu Y, He S, Li Y, et al
    Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Heliyon. 2023;9:e13707.
    Abstract     Related articles   

  485. LI T, Jiang N, Bai Y, Liu T, et al
    Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.
    Heliyon. 2023;9:e13661.
    Abstract     Related articles   

  486. CHEN R, Jiang M, Hu B, Fu B, et al
    Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Int J Gen Med. 2023;16:707-722.
    Abstract     Related articles   

  487. ST-LAURENT MP, Suderman J, Black PC
    Where To Draw the Line: Stratifying Risk for High-grade Ta Bladder Cancer.
    Eur Urol Oncol. 2023 Mar 3:S2588-9311(23)00035-4. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  488. ANDRIKOS I, Stefanou K, Bellos C, Stergios G, et al
    EDIT Software: A tool for the semi-automatic 3D reconstruction of bladder cancer and urinary bladder of animal models.
    Comput Methods Programs Biomed. 2023;232:107448.
    Abstract     Related articles   

  489. WHYNOT EG, Tomko AM, Dupre DJ
    Anticancer properties of cannabidiol and Delta(9)-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.
    J Cannabis Res. 2023;5:7.
    Abstract     Related articles   

  490. CARVALHO LB, Martinez JLC, Lodeiro C, Bento R, et al
    Biochemical network analysis of protein-protein interactions to follow-up T1 bladder cancer patients.
    J Proteomics. 2023 Mar 2:104865. doi: 10.1016/j.jprot.2023.104865.
    Abstract     Related articles   

  491. IZAWA M, Tanaka N, Murakami T, Anno T, et al
    Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.
    Lab Invest. 2023;103:100040.
    Abstract     Related articles   

  492. AMEEN YA, Badary DM, Abonnoor AEI, Hussain KF, et al
    Which data subset should be augmented for deep learning? a simulation study using urothelial cell carcinoma histopathology images.
    BMC Bioinformatics. 2023;24:75.
    Abstract     Related articles   

  493. BUKAVINA L, Isali I, Ginwala R, Sindhani M, et al
    Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
    Eur Urol Oncol. 2023 Mar 1:S2588-9311(23)00036-6. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  494. LI KD, Chu CE, Patel M, Meng MV, et al
    Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer.
    Urol Oncol. 2023 Mar 1:S1078-1439(23)00009-1. doi: 10.1016/j.urolonc.2023.
    Abstract     Related articles   

  495. HERZOG RW, Suzuki M
    Adenoviral gene therapy for bladder cancer.
    Cell. 2023;186:893.
    Abstract     Related articles   

  496. ZENG SP, Sun YF, Ye JB, Zeng K, et al
    Transurethral en bloc resection of a bladder perivascular epithelioid cell tumor (PEComa): a case report.
    BMC Urol. 2023;23:28.
    Abstract     Related articles   

  497. FONTUGNE J, Wong J, Cabel L, Neyret-Kahn H, et al
    Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.
    J Pathol. 2023;259:455-467.
    Abstract     Related articles   

  498. GERALD T, Margulis V, Meng X, Bagrodia A, et al
    Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients.
    Urol Oncol. 2023;41:148.
    Abstract     Related articles   

  499. SETYO LC, Donahoe SL, Shearer PL, Wang P, et al
    Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-beta, and CDK4 in canine urothelial carcinoma.
    J Vet Diagn Invest. 2023;35:109-115.
    Abstract     Related articles   

  500. MIYAKE M, Shimizu T, Oda Y, Tachibana A, et al
    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.
    Jpn J Clin Oncol. 2023;53:253-262.
    Abstract     Related articles   

  501. BARLETTA F, Tappero S, Panunzio A, Incesu RB, et al
    Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
    Urol Oncol. 2023;41:147.
    Abstract     Related articles   

  502. WOLDU SL, Labbate C, Murray KS, Rose K, et al
    Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
    Urol Oncol. 2023;41:147.
    Abstract     Related articles   

  503. MIYAKE M, Oda Y, Owari T, Iida K, et al
    Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer.
    Cancer Sci. 2023;114:1118-1130.
    Abstract     Related articles   

  504. CHEN Y, Fu J, Li Z, Chen Q, et al
    Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma.
    Cancer Cytopathol. 2023;131:179-187.
    Abstract     Related articles   

  505. MATUTE GUERRERO A, Abanses Moreno P, Villasmil Chaparro I
    Pulmonary thrombotic microangiopathy caused by neoplastic urothelial carcinoma cells.
    Med Clin (Barc). 2023;160:226-227.
    Abstract     Related articles   

  506. QIWEI C, Jiajun S, Cheng L, Shengbo H, et al
    Comparison between renal pelvic and ureteral tumors in muscle-invasive upper tract urothelial carcinoma.
    Cancer Sci. 2023;114:984-994.
    Abstract     Related articles   

  507. PIERCONTI F, Rossi ED, Cenci T, Carlino A, et al
    DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group.
    Cancer Cytopathol. 2023;131:158-164.
    Abstract     Related articles   

  508. SEKINE Y, Iwasaki Y, Hakozaki N, Endo M, et al
    Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
    Jpn J Clin Oncol. 2022;52:1441-1445.
    Abstract     Related articles   

  509. BLINOVA E, Samishina E, Deryabina O, Blinov D, et al
    Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.
    Int J Mol Sci. 2021;22:9856.
    Abstract     Related articles   

  510. LEE HW, Seo HK
    Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment.
    Int J Mol Sci. 2021;22:9526.
    Abstract     Related articles   

  511. LOPEZ-CORTES R, Gomez BB, Vazquez-Estevez S, Perez-Fentes D, et al
    Blood-based protein biomarkers in bladder urothelial tumors.
    J Proteomics. 2021;247:104329.
    Abstract     Related articles   

  512. MARANDINO L, Raggi D, Calareso G, Alessi A, et al
    Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial.
    Clin Genitourin Cancer. 2021;19:457-465.
    Abstract     Related articles   

  513. POND GR, Agarwal A, Ornstein M, Garcia J, et al
    Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors.
    Clin Genitourin Cancer. 2021;19:425-433.
    Abstract     Related articles   

  514. STOKKEL LE, Stokkel MPM, Donswijk ML, Lahaye MJ, et al
    The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
    Clin Genitourin Cancer. 2021;19:373-380.
    Abstract     Related articles   

  515. RUNDO F, Bersanelli M, Urzia V, Friedlaender A, et al
    Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy.
    Clin Genitourin Cancer. 2021;19:396-404.
    Abstract     Related articles   

  516. CH'NG ES
    Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
    Sci Rep. 2021;11:6765.
    Abstract     Related articles   

  517. LEE Y, Kim YS, Hong B, Cho YM, et al
    Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC.
    J Cancer Res Clin Oncol. 2021;147:3421-3429.
    Abstract     Related articles   

  518. AGNIHOTRI MA, Sathe PA
    Coexistent urothelial papilloma and ureteric calculus in an 8-year-old child: A rare co-occurrence.
    J Postgrad Med. 2021;67:182-183.
    Abstract     Related articles   

  519. HUANG Y, Xie C, Li Q, Huang X, et al
    Prognostic factors and nomogram for the overall survival of bladder cancer bone metastasis: A SEER-based study.
    Medicine (Baltimore). 2023;102:e33275.
    Abstract     Related articles   

  520. SEMENIUK-WOJTAS A, Poddebniak-Strama K, Modzelewska M, Baryla M, et al
    Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2023 Mar 16. doi: 10.1007/s00262-023-03376.
    Abstract     Related articles   

  521. KE M, Sun N, Lin Z, Zhang P, et al
    SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.
    Cancer Cell Int. 2023;23:48.
    Abstract     Related articles   

  522. JARIMBA R, Quaresma V, Pedroso Lima J, Eliseu M, et al
    Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study.
    Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11026.
    Abstract     Related articles   

  523. TZELVES L, Katsimperis S, Bellos T, Berdempes M, et al
    Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study.
    Arch Ital Urol Androl. 2023 Mar 15. doi: 10.4081/aiua.2023.11266.
    Abstract     Related articles   

  524. LI Z, Zhao J, Huang X, Wang J, et al
    An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Sci Rep. 2023;13:4302.
    Abstract     Related articles   

  525. VAN GINKEL N, van Gennep EJ, Oosterbaan L, Greidanus J, et al
    Added Clinical Value of (18)F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.
    Clin Genitourin Cancer. 2023 Feb 22:S1558-7673(23)00037.
    Abstract     Related articles   

  526. ZHANG W, Zhang Z, Xiao W, Wang Y, et al
    Multiple directional DWI combined with T2WI in predicting muscle layer and Ki-67 correlation in bladder cancer in 3.0-T MRI.
    Cancer Med. 2023 Mar 14. doi: 10.1002/cam4.5782.
    Abstract     Related articles   

  527. ZHU J, Livasy C, Donahue EE, Symanowski JT, et al
    Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
    Transl Androl Urol. 2023;12:228-240.
    Abstract     Related articles   

  528. TAN Z, Chen Z, Yao G, Mumin MA, et al
    Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER databas
    Transl Androl Urol. 2023;12:330-346.
    Abstract     Related articles   

  529. YING Y, Wang Z, Tan Y, Cao H, et al
    Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer.
    Transl Androl Urol. 2023;12:176-186.
    Abstract     Related articles   

  530. YUAN F, Yin XY, Huang Y, Cai XW, et al
    Exosomal miR-93-5p as an important driver of bladder cancer progression.
    Transl Androl Urol. 2023;12:286-299.
    Abstract     Related articles   

  531. WANG SS, Zhai GQ, Huang ZG, Luo JY, et al
    Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75.
    Naunyn Schmiedebergs Arch Pharmacol. 2023.
    Abstract     Related articles   

  532. VAN HOOGSTRATEN LMC, Vrieling A, van der Heijden AG, Kogevinas M, et al
    Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.
    Nat Rev Clin Oncol. 2023 Mar 13. doi: 10.1038/s41571-023-00744.
    Abstract     Related articles   

  533. ZHANG X, Liu H, Zhang J, Wang Z, et al
    Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.
    Arch Esp Urol. 2023;76:70-83.
    Abstract     Related articles   

  534. CATA ED, Andras I, Popa A, Medan P, et al
    Robotic Radical Cystectomy with Intracorporeal Urinary Diversion - Tips and Tricks.
    Chirurgia (Bucur). 2023;118:63-72.
    Abstract     Related articles   

  535. XU Y, Xia Z, Sun X, Wei B, et al
    Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer.
    Front Immunol. 2023;14:1111319.
    Abstract     Related articles   

  536. HU B, Chen R, Chen G, Zheng P, et al
    Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy.
    Front Surg. 2023;10:1121184.
    Abstract     Related articles   

  537. ILLIAS AM, Yu KJ, Wu SC, Cata JP, et al
    Association of regional anesthesia with oncological outcomes in patients receiving surgery for bladder cancer: A meta-analysis of observational studies.
    Front Oncol. 2023;13:1097637.
    Abstract     Related articles   

  538. BORDELEAU F, Brownell D, Chabaud S, Huot ME, et al
    Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression.
    Stem Cell Investig. 2023;10:5.
    Abstract     Related articles   

  539. TIAN YQ, Yang JC, Hu JJ, Ding R, et al
    Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019.
    Front Public Health. 2023;11:1119374.
    Abstract     Related articles   

  540. YANAGISAWA T, Miki J, Matsukawa A, Iwatani K, et al
    ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?
    Ann Surg Oncol. 2023 Mar 12. doi: 10.1245/s10434-023-13291.
    Abstract     Related articles   

  541. LI J, Qiu Z, Cao K, Deng L, et al
    Predicting muscle invasion in bladder cancer based on MRI: A comparison of radiomics, and single-task and multi-task deep learning.
    Comput Methods Programs Biomed. 2023;233:107466.
    Abstract     Related articles   

  542. GROBET-JEANDIN E, Lenfant L, Mir C, Giannarini G, et al
    A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Mar 9:S2588-9311(23)00040-8. doi: 10.1016/j.euo.2023.
    Abstract     Related articles   

  543. PHILIPPS L, Porta N, James N, Huddart R, et al
    Differences in Quality of Life and Toxicity for Male and Female Patients following Chemo(radiotherapy) for Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2023 Feb 11:S0936-6555(23)00052.
    Abstract     Related articles   

  544. ZHANG P, Sun Y, Shi L, Sun D, et al
    Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARgamma/PTEN/AKT pathway.
    Tissue Cell. 2023;82:102048.
    Abstract     Related articles   

  545. ZHU H, Chen Q, Zhang Y, Zhao L, et al
    Glutathione S-transferase zeta 1 alters the HMGB1/GPX4 axis to drive ferroptosis in bladder cancer cells.
    Hum Exp Toxicol. 2023;42:9603271231161606.
    Abstract     Related articles   

  546. HANNA DH, Aziz MM, Shafee EE
    Effective-by-method for the preparation of folic acid coated TiO(2) nanoparticles with high targeting potential for apoptosis induction against bladder cancer cells (T24).
    Biotechnol Appl Biochem. 2023 Mar 11. doi: 10.1002/bab.2456.
    Abstract     Related articles   

  547. PEREIRA IOA, da Silva GN, Almeida TC, Lima APB, et al
    LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells.
    Molecules. 2023;28:2412.
    Abstract     Related articles   

  548. WANG Z, Wang T, Wu G, Zhu L, et al
    Clinical Significance and Tumor Microenvironment Characterization of a Novel Immune-Related Gene Signature in Bladder Cancer.
    J Clin Med. 2023;12:1892.
    Abstract     Related articles   

  549. FLAMMIA RS, Tufano A, Chierigo F, Wurnschimmel C, et al
    The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer.
    J Clin Med. 2023;12:1776.
    Abstract     Related articles   

  550. MURAKAMI K, Furuya H, Hokutan K, Goodison S, et al
    Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer.
    Int J Mol Sci. 2023;24:4943.
    Abstract     Related articles   

  551. MA L, Chen H, Yang W, Ji Z, et al
    Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients.
    Int J Mol Sci. 2023;24:4760.
    Abstract     Related articles   

  552. TORTORA F, La Civita E, Trivedi P, Febbraio F, et al
    Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers.
    Int J Mol Sci. 2023;24:4601.
    Abstract     Related articles   

  553. ZUCCHI A, Claps F, Pastore AL, Perotti A, et al
    Focus on the Use of Resveratrol in Bladder Cancer.
    Int J Mol Sci. 2023;24:4562.
    Abstract     Related articles   

  554. ZHU J, Li Y, Luo Y, Xu J, et al
    Correction: Zhu et al. A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-like Properties and Invasion in Human Bladder Cancer. Cancers 2019, 11, 349.
    Cancers (Basel). 2023;15:1403.
    Abstract     Related articles   

  555. HURLE R, Soria F, Contieri R, Avolio PP, et al
    Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial.
    Cancers (Basel). 2023;15:1618.
    Abstract     Related articles   

  556. CELADA LUIS G, Albers Acosta E, de la Fuente H, Velasco Balanza C, et al
    A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer.
    Cancers (Basel). 2023;15:1364.
    Abstract     Related articles   

  557. HU X, Xue Y, Zhu G
    Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
    Diagnostics (Basel). 2023;13:1004.
    Abstract     Related articles   

  558. VAROL N, Keles I, Yildiz H, Karaosmanoglu C, et al
    Methylation analysis of histone 4-related gene HIST1H4F and its effect on gene expression in bladder cancer.
    Gene. 2023;866:147352.
    Abstract     Related articles   

  559. ASCIONE CM, Napolitano F, Esposito D, Servetto A, et al
    Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
    Cancer Treat Rev. 2023;115:102530.
    Abstract     Related articles   

  560. WANG J, Meng X, Yu M, Li X, et al
    A novel microfluidic system for enrichment of functional circulating tumor cells in cancer patient blood samples by combining cell size and invasiveness.
    Biosens Bioelectron. 2023;227:115159.
    Abstract     Related articles   

  561. KUMAR R, Harilal S, Abdelgawad MA, Ghoneim MM, et al
    Urachal carcinoma: The journey so far and the road ahead.
    Pathol Res Pract. 2023;243:154379.
    Abstract     Related articles   

  562. WANG P, Shi Y, Zhang J, Shou J, et al
    UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA.
    EBioMedicine. 2023;89:104437.
    Abstract     Related articles   

  563. WANG L, Shi G, Zhao G, He W, et al
    Efficacy and safety of enfortumab vedotin in the treatment of advanced urothelial carcinoma: a systematic review and meta-analysis.
    Anticancer Drugs. 2023;34:473-478.
    Abstract     Related articles   

  564. JIN J, Yang Q, Yu Y, Chen L, et al
    Complete response to tislelizumab in a metastatic urothelial carcinoma after surgery associated with high tumor mutational burden: a case report.
    Anticancer Drugs. 2023;34:595-598.
    Abstract     Related articles   

  565. FATIMA A, Russell DH, Epstein JI
    Nested Subtype of Urothelial Carcinoma in the Upper Urinary Tract: A Series of 15 Cases.
    Am J Surg Pathol. 2023;47:461-468.
    Abstract     Related articles   

  566. CALEN L, Mesnard B, Hedhli O, Broudeur L, et al
    Robot-assisted laparoscopic cystectomy with non-continent urinary diversion for neurogenic lower urinary tract dysfunction: Midterm outcomes.
    Neurourol Urodyn. 2023;42:586-596.
    Abstract     Related articles   

  567. ZHAO Q, Wu L, Yang F, Han S, et al
    Application of Transvaginal Natural Orifice Specimen Extraction Surgery in Urological Surgery.
    J Laparoendosc Adv Surg Tech A. 2023;33:231-235.
    Abstract     Related articles   

  568. WU W, Jing Y, Xu Q, Hao J, et al
    MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway.
    Panminerva Med. 2023;65:114-115.
    Abstract     Related articles   

  569. HASHIMOTO M, Fujita K, Tomiyama E, Fujimoto S, et al
    Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.
    Anticancer Res. 2023;43:167-174.
    Abstract     Related articles   

  570. TOMISAKI I, Harada M, Sakano S, Terado M, et al
    Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab.
    Anticancer Res. 2023;43:269-274.
    Abstract     Related articles   

  571. CHEN SY, Chao CN, Huang HY, Zhao PW, et al
    Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and Bladder Urothelial Carcinoma Cells.
    Anticancer Res. 2023;43:1175-1184.
    Abstract     Related articles   

  572. LI JR, Wang SS, Lu K, Chen CS, et al
    First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study.
    Anticancer Res. 2023;43:1331-1339.
    Abstract     Related articles   

  573. VON DEIMLING M, Rink M, Klemm J, Koelker M, et al
    Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy.
    BJU Int. 2023;131:90-100.
    Abstract     Related articles   

  574. CLAPS F, van de Kamp MW, Mayr R, Bostrom PJ, et al
    Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy.
    BJU Int. 2023 Feb 6. doi: 10.1111/bju.15984.
    Abstract     Related articles   

  575. MIGNOT F, Fabiano E, Xylinas E, Alati A, et al
    Clinical outcomes of adapted hypofractionated radiotherapy for bladder cancer in elderly patients.
    BJU Int. 2023 Feb 6. doi: 10.1111/bju.15983.
    Abstract     Related articles   

  576. NURMINEN P, Ettala O, Uusitalo-Seppala R, Hogerman M, et al
    Clinical presentation of bacille Calmette-Guerin (BCG) infections after BCG instillation therapy.
    BJU Int. 2023;131:306-312.
    Abstract     Related articles   

    Letter to the editor regarding the article 'Do we need repeat transurethral resection after en-bloc resection for pathological T1 bladder cancer?
    BJU Int. 2023 Mar 10. doi: 10.1111/bju.16005.
    Abstract     Related articles   

  578. XU L, Zhong W, Li C, Hong P, et al
    The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study).
    Br J Cancer. 2023;128:310-320.
    Abstract     Related articles   

  579. TSAI YC, Wang TY, Hsu CL, Lin WC, et al
    Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling.
    Br J Cancer. 2023 Feb 21. doi: 10.1038/s41416-023-02195.
    Abstract     Related articles   

  580. VASDEV N
    Multicentric validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring in two prospective cohorts of patients.
    Br J Cancer. 2023 Mar 1. doi: 10.1038/s41416-023-02142.
    Abstract     Related articles   

  581. QIU H, Makarov V, Bolzenius JK, Halstead A, et al
    KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer.
    Cancer Res. 2023 Jan 13:CAN-22-1444. doi: 10.1158/0008-5472.CAN-22-1444.
    Abstract     Related articles   

  582. CASWELL D, Swanton C
    Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
    Cancer Res. 2023;83:487-488.
    Abstract     Related articles   

  583. CHOPRA S, Trepka K, Sakhamuri S, Carretero-Gonzalez A, et al
    Theranostic targeting of CUB domain containing protein 1 (CDCP1) in multiple subtypes of bladder cancer.
    Clin Cancer Res. 2023 Jan 17:CCR-22-1973. doi: 10.1158/1078-0432.CCR-22-1973.
    Abstract     Related articles   

  584. MISHRA A, Kumar D, Gupta K, Lofland G, et al
    Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics.
    Clin Cancer Res. 2023;29:581-591.
    Abstract     Related articles   

  585. CHRISTENSEN E, Nordentoft I, Birkenkamp-Demtroder K, Elbaek SK, et al
    Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer.
    Clin Cancer Res. 2023 Feb 13:CCR-22-3250. doi: 10.1158/1078-0432.CCR-22-3250.
    Abstract     Related articles   

  586. PAPADIMITRIOU MA, Levis P, Kotronopoulos G, Stravodimos K, et al
    Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
    Clin Chem. 2023 Feb 4:hvac218. doi: 10.1093.
    Abstract     Related articles   

  587. HORNAK J, Brisuda A, Babjuk M
    Transurethral resection of bladder cancer with or without fluorescence.
    Curr Opin Urol. 2023 Jan 12. doi: 10.1097/MOU.0000000000001071.
    Abstract     Related articles   

  588. WALZ S, Aslani V, Sawodny O, Stenzl A, et al
    Robotic radical cystectomy - more precision needed?
    Curr Opin Urol. 2023;33:157-162.
    Abstract     Related articles   

  589. TONIN E, Shariat SF, Schiavina R, Brunocilla E, et al
    En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?
    Curr Opin Urol. 2023;33:147-151.
    Abstract     Related articles   

  590. MUIN D, Laukhtina E, Hacker M, Shariat SF, et al
    PET in bladder cancer imaging.
    Curr Opin Urol. 2023 Mar 7. doi: 10.1097/MOU.0000000000001090.
    Abstract     Related articles   

  591. ST-LAURENT MP, Suderman J, Black PC
    Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Jan 3:S0302-2838(22)02866-4. doi: 10.1016/j.eururo.2022.
    Abstract     Related articles   

  592. KLUMPER N, Holzel M, Eckstein M
    Reply to Jon Griffin. TIME for a Change? Multimarker Assessment of the Tumour Immune Microenvironment and Metastatic Site Biopsy to Improve Immunotherapy Response Prediction in Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.101
    Eur Urol. 2023 Jan 24:S0302-2838(23)00022-2. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  593. QUAN C, Chen J, Hu J
    Re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.
    Eur Urol. 2023 Jan 24:S0302-2838(23)00020-9. doi: 10.1016/j.eururo.2022.
    Abstract     Related articles   

  594. HAHN NM, O'Donnell MA, Efstathiou JA, Zahurak M, et al
    A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.
    Eur Urol. 2023 Jan 28:S0302-2838(23)00025-8. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  595. PRADERE B, Basile G, Seisen T
    Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjot, Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a
    Eur Urol. 2023 Jan 28:S0302-2838(23)00024-6. doi: 10.1016/j.eururo.2022.
    Abstract     Related articles   

  596. PAOLO G, Francesco S
    Re: Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
    Eur Urol. 2023 Jan 27:S0302-2838(23)00014-3. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  597. LINDGREN MS, Jensen JB
    Reply to Benjamin Pradere, Giuseppe Basile, and Thomas Seisen's Letter to the Editor re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjot, Jorgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chem
    Eur Urol. 2023 Jan 27:S0302-2838(23)00023-4. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  598. BASILE G, Bandini M, Montorsi F, Necchi A, et al
    Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Foll
    Eur Urol. 2023 Jan 25:S0302-2838(23)00021-0. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  599. ERLMEIER F, Klumper N, Landgraf L, Strissel PL, et al
    Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition.
    Eur Urol. 2023;83:133-142.
    Abstract     Related articles   

  600. PEDERSEN GL, Erikson MS, Mogensen K, Rosthoj S, et al
    Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A P
    Eur Urol. 2023;83:125-130.
    Abstract     Related articles   

  601. SUDERMAN J, St-Laurent MP, Black PC
    Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Feb 1:S0302-2838(23)00016-7. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  602. DE ANGELIS M, Briganti A, Montorsi F, Moschini M, et al
    Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Feb 16:S0302-2838(23)02571-X. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  603. SYLVESTER RJ, Rodriguez O, Hernandez V, Turturica D, et al
    Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
    Eur Urol. 2023 Feb 23:S0302-2838(23)02579-4. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  604. STENZL A, Roupret M, Witjes JA, Gontero P, et al
    High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of Tumour Delineation.
    Eur Urol. 2023;83:193-194.
    Abstract     Related articles   

  605. GIL-JIMENEZ A, van Dorp J, Contreras-Sanz A, van der Vos K, et al
    Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].
    Eur Urol. 2023 Mar 10:S0302-2838(23)02641-6. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  606. MAITRE P, Sangar V, Choudhury A
    ADAPT and Improvise: Overcoming Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Mar 8:S0302-2838(23)02627-1. doi: 10.1016/j.eururo.2023.
    Abstract     Related articles   

  607. MOLINA GE, Schwartz B, Srinivas S, Shah S, et al
    In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity.
    Eur Urol. 2023;83:377-378.
    Abstract     Related articles   

  608. BERGEROT CD, Gupta S
    Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in the Current Therapeutic Era?
    Eur Urol. 2023;83:329-330.
    Abstract     Related articles   

  609. GRIVAS P, Kopyltsov E, Su PJ, Parnis FX, et al
    Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
    Eur Urol. 2023;83:320-328.
    Abstract     Related articles   

  610. VIDRA N, Beeren I, van Zutphen M, Aben KK, et al
    Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer.
    Int J Cancer. 2023 Jan 3. doi: 10.1002/ijc.34418.
    Abstract     Related articles   

  611. HIEN TT, Ambite I, Wan MLY, Cavalera M, et al
    Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy.
    Int J Cancer. 2023 Mar 9. doi: 10.1002/ijc.34500.
    Abstract     Related articles   

  612. NAKAMURA Y, Fukushima H, Yoshitomi K, Soma T, et al
    Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer.
    Int J Urol. 2022 Dec 27. doi: 10.1111/iju.15136.
    Abstract     Related articles   

  613. NASELLI A, Pirola GM
    Editorial Comment to Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer.
    Int J Urol. 2023 Jan 18. doi: 10.1111/iju.15150.
    Abstract     Related articles   

  614. KATAYAMA S, Pradere B, Grossman NC, Potretzke AM, et al
    Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
    Int J Urol. 2023;30:63-69.
    Abstract     Related articles   

  615. MIYAMOTO T, Miyake M, Nakahama T, Nishimura N, et al
    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
    Int J Urol. 2023 Feb 14. doi: 10.1111/iju.15162.
    Abstract     Related articles   

  616. YANG H, Zhang Z, Zhao K, Zhang Y, et al
    Initial experience with 161 extraperitoneal laparoscopic radical cystectomy procedures: Comparison with transabdominal laparoscopic radical cystectomy.
    Int J Urol. 2023;30:155-160.
    Abstract     Related articles   

  617. MOEEN AM
    Editorial Comment on Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the incidence of catheter-related bladder discomfort in TURBT: A randomized, double-blind, controlled trial.
    Int J Urol. 2023;30:270-271.
    Abstract     Related articles   

  618. CHEN W, Yokoyama M, Kobayashi M, Fan B, et al
    Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study.
    Int J Urol. 2023;30:258-263.
    Abstract     Related articles   

  619. MIYAKE M, Oda Y, Nishimura N, Shimizu T, et al
    Chemotherapy with gemcitabine and cisplatin downregulates tumor expression level of nectin-4 in a syngeneic model of murine MBT2 urothelial cancer cell line and C3H mice.
    Int J Urol. 2023;30:328-330.
    Abstract     Related articles   

  620. SINGH A, Kayina CA, Naik N, Ganesh V, et al
    Transurethral lidocaine (100 mg) bladder irrigation (TULI100) reduces the incidence of catheter related bladder discomfort in transurethral resection of bladder tumors: A randomized, double blind, controlled trial.
    Int J Urol. 2023;30:264-270.
    Abstract     Related articles   

    Editorial Comment on Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
    Int J Urol. 2023 Mar 16. doi: 10.1111/iju.15177.
    Abstract     Related articles   

  622. CANO GARCIA C, Piccinelli ML, Tappero S, Panunzio A, et al
    Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
    Int Urol Nephrol. 2023 Feb 23. doi: 10.1007/s11255-023-03517.
    Abstract     Related articles   

  623. DEWITT-FOY ME, Anele UA, Accioly JPE, Sharpe MG, et al
    Cancer risk in bladder diverticula: a large institutional analysis of risk and management.
    Int Urol Nephrol. 2023;55:541-546.
    Abstract     Related articles   

  624. QIU Y, Zhang X, Dong Z, Zhang Y, et al
    Comparable survival benefits of partial ureterectomy to radical nephroureterectomy in non-metastatic ureter carcinoma: a population-matched study.
    Int Urol Nephrol. 2023;55:579-588.
    Abstract     Related articles   

  625. GRIZZI F, Hegazi MAAA, Taverna G
    Letter to the editor re: "assessing bladder cancer prognosis through circulating tumor cell analysis and Ki-67 measurement".
    Int Urol Nephrol. 2023 Mar 3. doi: 10.1007/s11255-023-03538.
    Abstract     Related articles   

  626. PLIMACK ER, Zibelman MR
    Platinum-Free Systemic Therapy in First-Line Metastatic Urothelial Carcinoma: Mirage or Oasis in the Platinum Desert?
    J Clin Oncol. 2023;41:7-10.
    Abstract     Related articles   

  627. CRABB SJ, Hussain S, Soulis E, Hinsley S, et al
    A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
    J Clin Oncol. 2023;41:54-64.
    Abstract     Related articles   

  628. ROSENBERG JE, Park SH, Kozlov V, Dao TV, et al
    Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
    J Clin Oncol. 2023;41:43-53.
    Abstract     Related articles   

  629. STERNBERG CN, Petrylak DP, Bellmunt J, Nishiyama H, et al
    FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.
    J Clin Oncol. 2023;41:629-639.
    Abstract     Related articles   

  630. SADEGHI S, Quinn D, Dorff T, Pal S, et al
    EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.
    J Clin Oncol. 2023;41:640-650.
    Abstract     Related articles   

  631. Erratum: DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.
    J Clin Oncol. 2023 Jan 25:JCO2202889. doi: 10.1200/JCO.22.02889.
    Abstract     Related articles   

  632. COLEMAN JA, Yip W, Wong NC, Sjoberg DD, et al
    Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
    J Clin Oncol. 2023;41:1618-1625.
    Abstract     Related articles   

  633. LYON TD, Boorjian SA, Tyson MD
    In-Home Intravesical Therapy: The Future of Non-muscle Invasive Bladder Cancer Care Delivery?. Letter.
    J Urol. 2023 Jan 13:101097JU0000000000003176. doi: 10.1097/JU.0000000000003176.
    Abstract     Related articles   

  634. PRUNTY M, Rhodes S, Rivero MJ, Callegari M, et al
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy.
    J Urol. 2023;209:329-336.
    Abstract     Related articles   

  635. HUELSTER HL, Zemp L, Turner K, Gonzalez BD, et al
    Mobile Postoperative Symptom Intervention Tool and Biometric Monitoring After Radical Cystectomy: Pilot Study Evaluating Feasibility, Usability, and Potential Utility.
    J Urol. 2023;209:410-421.
    Abstract     Related articles   

  636. CASTANEDA PR, Ahdoot M, Rosser CJ
    Re: Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomyis Prognostic but Not Therapeutic.
    J Urol. 2023 Feb 8:101097JU0000000000003362. doi: 10.1097/JU.0000000000003362.
    Abstract     Related articles   

  637. PRUNTY M, Shoag J
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply.
    J Urol. 2023;209:508-509.
    Abstract     Related articles   

  638. VANDEN BERG RNW, Abern M
    National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Letter.
    J Urol. 2023;209:508.
    Abstract     Related articles   

  639. MASTROIANNI R, Ochoa Arvizo MA, Torregiani G, Simone G, et al
    Robot-assisted vs Open Radical Cystectomy: Randomized Controlled Trials Lights and Shadows.
    J Urol. 2023;209:460-461.
    Abstract     Related articles   

  640. TISSOT G, Xylinas E
    Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    J Urol. 2023;209:462-463.
    Abstract     Related articles   

  641. PALLAUF M, D'Andrea D, Konig F, Laukhtina E, et al
    Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.
    J Urol. 2023;209:515-524.
    Abstract     Related articles   

  642. MYERS A, Frank I, Shah PH, Tarrell RF, et al
    Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy.
    J Urol. 2023;209:525-531.
    Abstract     Related articles   

  643. PENG CK, Sung WW, Chen SL
    Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
    J Urol. 2023 Mar 9:101097JU0000000000003407. doi: 10.1097/JU.0000000000003407.
    Abstract     Related articles   

  644. PENG CK, Sung WW
    Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification. Letter.
    J Urol. 2023;209:676-677.
    Abstract     Related articles   

  645. LOTAN Y, Raman JD, Konety B, Daneshmand S, et al
    Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
    J Urol. 2023;209:762-772.
    Abstract     Related articles   

  646. SUN J, Zhang H, Wei W, Xiao X, et al
    Regulation of CD8(+) T cells infiltration and immunotherapy by circMGA/HNRNPL complex in bladder cancer.
    Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02637.
    Abstract     Related articles   

  647. BRUN A, Koutlidis N, Thibault T, Escoffier A, et al
    [The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].
    Prog Urol. 2023 Jan 3:S1166-7087(22)00537-1. doi: 10.1016/j.purol.2022.
    Abstract     Related articles   

  648. AUDENET F, Neuzillet Y, Roupret M
    [Photodynamic-guided transurethral resection: Uncertainties brought to light].
    Prog Urol. 2023;33:56-57.
    Abstract     Related articles   

  649. GABRIEL PE, Pinar U, Parra J, Vaessen C, et al
    [Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review].
    Prog Urol. 2023;33:145-154.
    Abstract     Related articles   

  650. CIMIER A, Thach S, Lacroix B, Mariat C, et al
    [Evaluation of the efficacy and safety of HIVEC intravesical thermochemotherapy with intermediate-risk and high-risk non-muscle-invasive bladder cancer].
    Prog Urol. 2023 Mar 9:S1166-7087(23)00062-3. doi: 10.1016/j.purol.2023.
    Abstract     Related articles   

  651. FITOUSSI O, Roche JB, Riviere J, Wallerand H, et al
    Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
    Urol Int. 2023 Jan 19:1-7. doi: 10.1159/000528524.
    Abstract     Related articles   

  652. TACHIBANA T, Ikeda M, Shimura S, Amano N, et al
    Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guerin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.
    Urol Int. 2023 Jan 16:1-9. doi: 10.1159/000527718.
    Abstract     Related articles   

  653. KORKES F, Timoteo F, Baccaglini W, Glina F, et al
    Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series.
    Urol Int. 2023;107:96-104.
    Abstract     Related articles   

  654. ZANG Z, Kesavan NR, Esuvaranathan K
    UBC(R)Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population.
    Urol Int. 2023;107:29-34.
    Abstract     Related articles   

  655. SCHNEIDEWIND L, Drager DL, Rossberg V, Nolting J, et al
    Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival.
    Urol Int. 2023;107:80-86.
    Abstract     Related articles   

  656. MICHAEL KGFT, Ravindranath N, Michael S, German A, et al
    Optimizing Upper-Tract Imaging for Non-Visible Haematuria.
    Urol Int. 2023;107:23-28.
    Abstract     Related articles   

  657. ZHANG Y, Ding H, Zhang Y, Tian J, et al
    Is Anti-Reflux Anastomosis an Advantage in an Orthotopic Ileal Neobladder? A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:1-14.
    Abstract     Related articles   

  658. EISMANN L, Bohn L, Buchner A, Casuscelli J, et al
    Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Urol Int. 2023;107:72-79.
    Abstract     Related articles   

  659. BOLAT D, Baltaci S, Akgul M, Karabay E, et al
    Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2023 Feb 21:1-7. doi: 10.1159/000528740.
    Abstract     Related articles   

  660. SHARMA V, Chamie K, Schoenberg M, Lee VS, et al
    Natural history of multiple recurrences in intermediate-risk non-muscle invasive bladder cancer: lessons from a prospective cohort.
    Urology. 2022 Dec 24:S0090-4295(22)01071-8. doi: 10.1016/j.urology.2022.
    Abstract     Related articles   

  661. INOUE T
    Association of increased age with decreased response to intravesical instillation of Bacille Calmette-Guerin in patients with high-risk non-muscle invasive bladder cancer: Retrospective multi-institute results from the Japanese Urological Oncology Res
    Urology. 2022 Dec 28:S0090-4295(22)01085-8. doi: 10.1016/j.urology.2022.
    Abstract     Related articles   

  662. TYSON MD, Mi L
    Preliminary Surgical Outcomes After Single Incision Robotic Cystectomy (SIRC).
    Urology. 2023;171:127-132.
    Abstract     Related articles   

  663. HOUENSTEIN HA, Jing Z, Elsayed AS, Ramahi YO, et al
    Analysis of Complications After Robot-Assisted Radical Cystectomy Between 2002-2021.
    Urology. 2023;171:133-139.
    Abstract     Related articles   

  664. AN L, Xiong L, Xu Q, Chen L, et al
    Incidental Diagnosis of Renal Pelvic Tumor in Patients Who Underwent Percutaneous Nephrolithotomy: A Report of 6 Cases and Review of the Literature.
    Urology. 2023;171:64-70.
    Abstract     Related articles   

  665. GOLZY M, Rosen G, Kruse RL, Hooshmand K, et al
    Holistic assessment of quality of life predicts survival in older patients with bladder cancer.
    Urology. 2023 Jan 17:S0090-4295(23)00045-6. doi: 10.1016/j.urology.2022.
    Abstract     Related articles   

  666. ALSYOUF M, Daneshmand S
    Late Complication of Orthotopic T-Pouch Ileal Neobladder Diversion.
    Urology. 2023;172:e1-e2.
    Abstract     Related articles   

  667. MAKEDON AM, Sadowsky A, Johnson BA, Walker DT, et al
    A Novel Technique of Robotic-Assisted Simple Cystectomy During Urinary Diversion for Benign Indications.
    Urology. 2023;172:234.
    Abstract     Related articles   

  668. BRITTON CJ, Gottlich HC, Tarrell RF, Thapa P, et al
    Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy.
    Urology. 2023;172:149-156.
    Abstract     Related articles   

  669. SUBIELA JD, Gonzalez-Padilla DA, Huguet J, Aumatell J, et al
    Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma.
    Urology. 2023;172:157-164.
    Abstract     Related articles   

  670. DOPPALAPUDI SK, Chua KJ, Tabakin AL, Park JH, et al
    Chemotherapy Refractory Spindle-Cell Rhabdomyosarcoma of the Bladder Treated with Consolidative Ovarian-Sparing Radical Surgery.
    Urology. 2022 Nov 16:S0090-4295(22)00953-0. doi: 10.1016/j.urology.2022.
    Abstract     Related articles   

  671. HUANG W, Zhu L, Huang H, Li Y, et al
    IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
    BMC Cancer. 2023;23:116.
    Abstract     Related articles   

  672. JUNG M, Rose M, Knuechel R, Loeffler C, et al
    Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
    BMC Cancer. 2023;23:113.
    Abstract     Related articles   

  673. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    Abstract     Related articles   

  674. FUJITA N, Hatakeyama S, Okita K, Momota M, et al
    Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.
    PLoS One. 2023;18:e0275921.
    Abstract     Related articles   

  675. AHRENFELDT J, Christensen DS, Ostergaard AB, Kisistok J, et al
    The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy.
    PLoS One. 2023;18:e0281375.
    Abstract     Related articles   

  676. LIEDBERG F, Hagberg O, Haggstrom C, Aljabery F, et al
    Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study.
    PLoS One. 2023;18:e0281304.
    Abstract     Related articles   

  677. WEINBERG L, Aitken SAA, Kaldas P, Fletcher L, et al
    Postoperative complications and hospital costs following open radical cystectomy: A retrospective study.
    PLoS One. 2023;18:e0282324.
    Abstract     Related articles   

  678. LIU CL, Tsai HW, Peng SL, Chang CP, et al
    CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma.
    PLoS One. 2023;18:e0281873.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.